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ABSTRACT
Staphylococcus aureus is a major human pathogen that causes lethal systemic
conditions such as infective endocarditis, osteomyelitis, sepsis and pneumonia. Chronic
in nature, these diseases are often refractory to the antibiotic treatment. Such recalcitrance
is mainly caused due to the presence of persister cells, which are a bacterial
subpopulation that exhibits extreme, yet transient antibiotic tolerance accompanied by a
transient halt in the growth. However, upon cessation of antibiotic treatment, resumption
in growth of persister cells causes recurrence of infections and treatment failure,
displaying tremendous clinical significance. In this study, we show the involvement of
the msaABCR operon in persister cells formation in S. aureus under clinically relevant
bactericidal antibiotics. Considering the importance of metabolism in antibiotic tolerance,
we demonstrate causal link between cellular energy and antibiotic tolerance in S. aureus.
We observe that the inactivation of the msaABCR operon in USA300 LAC led to
increased tricarboxylic acid (TCA) cycle activity, cellular ATP and NADH content, and
membrane potential. The increased ATP in the msaABCR mutant during late exponentialphase led to decreased persister formation against different antibiotic stress, while the
increased membrane potential in the stationary-phase led to defective persister formation
against aminoglycoside stress. Furthermore, we show msaABCR (MsaB) as a
transcriptional repressor of catabolite control protein E (ccpE), an activator of TCA cycle,
and nicotinamide dehydrogenase (ndh2), the gene of electron transport chain (ETC) in S.
aureus.
Deletion of the msaABCR operon resulted in the downregulated expression of
several genes involved in resistance against oxidative stress. Notably, those included
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carotenoid biosynthetic genes (crtM/N), OsmC/Ohr family protein (ohr) and catalase
(katA) genes. Here, we report the transcriptional regulation of the crtOPQMN operon and
the ohr gene by the msaABCR operon. In addition, we also show MsaB as the
transcriptional activator of sigB (transcriptional regulator of the crtOPQMN operon) and
transcriptional repressor of sarZ (repressor of ohr). These results suggest that the
msaABCR operon regulates an oxidative-stress defense mechanism, which is required to
facilitate persistent and recurrent staphylococcal infections. In conclusion, we
demonstrate the importance of the msaABCR operon in S. aureus survival in different
stressful environment.
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CHAPTER I - INTRODUCTION
1.1 Staphylococcus aureus
Staphylococcus aureus, a gram positive, non-motile and non-spore forming
coccoid bacterium, belongs to the phylum Firmicutes and class Bacilli. The bacterium is
facultative anaerobe that measures 0.7-1.2 μm in diameter. The genus Staphylococcus
comprised of 52 species and 28 subspecies
(https://www.bacterio.net/genus/staphylococcus), among which S. aureus is the most
common pathogen that causes varieties of infections in human. In 1882, Ogston coined
the term “staphylococci”, derived from Greek staphyle meaning bunch of grape, and
kokkos meaning berry, referring to the bacterial structures as observed under microscope
while examining the pus from a surgical abscess (1). In 1884, Rosenbach noted two
different types of colonies: white and pigmented. S. aureus was derived from the Latin
aurum meaning gold, referring to its characteristic golden colonies when grown on solid
media, and S. albus for white colonies, later renamed as S. epidermidis because of its
high prevalence on the human skin (2). In 1903, Loeb observed pronounced coagulative
property of S. aureus when tested with the blood (3). S. aureus is now identified and
differentiated based on coagulase positive test (ability to clot blood plasma) from other
staphylococci species that are grouped under coagulase negative staphylococci (CNS).
Moreover, S. aureus is positive on heat stable deoxyrobinuclease (Dnase) and the protein
A hemagglutination tests (4). Likewise, S. aureus is catalase positive, the characteristic of
S. aureus that produce catalase enzyme, a distinct phenomenon used to differentiate the
pathogen from streptococci.
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The human skin microbiome constitutes the staphylococcal species including S.
aureus. An estimated of 30% of total human population harbors S. aureus as
commensals on the skin surface or the anterior nares (5, 6). The successful colonization
by S. aureus is acquired through various adhesins, surface proteins and secreted enzymes
that withstand the lethality of antimicrobial peptides or enzymes, and lipids present on the
human skin (7). However, loss of normal skin barrier, underlying immunocompromised
conditions predisposes an individual to S. aureus infections.
S. aureus is a versatile pathogen that proliferates in wide range of hosts and their
tissues. While the optimal growth is observed under aerobic conditions, S. aureus can
also withstand the microaerophilic conditions, which facilitates the biofilm associated
deep seated infections (8). In response to the environmental stresses occurred during the
course of infection, S. aureus frequently undergoes mutations in the metabolic genes that
form distinct small colony variants (SCVs), which are known to be more persistent inside
the host cells (9). These strategies altogether benefit the S. aureus by conferring the
pathogen survival in the stressful host environment.
1.1.1 S. aureus is a Public Health Burden
S. aureus is a major bacterial pathogen that can cause remarkably diverse array of
infections ranging from acute skin infections to systemic and often life-threatening
conditions such as endocarditis, bacteremia, osteomyelitis and pneumonia (10). This
versatility of the pathogen is due to the possession of plethora of virulence factors,
acquisition of antibiotic resistance, and its ability to evade and invade the host immune
cells (10-12). Besides, S. aureus being a commensal inhabitant of skin and nasal carriers
2

also contributes for its prominence as an opportunistic human pathogen (13). For
instance, S. aureus causes ~76% of all skin and soft tissue infections (14) accounting for
10 million hospital visits annually (15). The immunocompromised individuals with
chronic conditions such as cancer, diabetes, vascular diseases or the patients undergoing
treatment with medical devices such as catheters and tips are more prone to S. aureus
infections (https://www.cdc.gov/hai/organisms/staph.html ). Indeed, the pathogen was
previously reported to be the leading cause of health care associated (HA) infections.
However, in the past decade, increasing emergence of community acquired (CA) S.
aureus infections have been threatening the public health. For instance, the methicillin
resistant S. aureus (MRSA) strain USA300 was reported to be the most common strain
that accounted for > 98% of the emergency cases of soft tissue infections in 11 U. S.
cities in 2004 (14). In the year 2017, Centre for Disease Control and Prevention (CDC)
reported >119,000 MRSA associated bacteremia cases with nearly 20 thousand deaths in
the U. S. (16). In addition, the MRSA is also reported to be the major cause of infective
endocarditis causing ~50 thousand incidences per year with average hospital cost
exceeding $120,000 per patient (17) and annual treatment cost of $ 4 to 30 billion in the
US alone (14). Due to its propensity to cause severe diseases and its ability to acquire
antibiotic resistance, S. aureus infections account for significant morbidity and mortality
(18). Furthermore, CA-MRSA infections could act as reservoir and contribute to HA
infections fueling the transmission both outside as well as within the health care facilities.
Indeed, USA300 strains were emerged in the community and spread to health care
settings subsequently causing epidemics in the US in early 2000 (19, 20). In addition to
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the US and Canada, CA-MRSA has been rapidly spreading to other continents and have
been reported from South America, Asia, Europe, and Australia (21). Despite the
tremendous clinical significance, there is absence of vaccination against S. aureus.
1.2 Persister Cells
In 1944, Bigger discovered and coined the term “persister cells” to denote a small
fraction of S. aureus cells that could not be killed by lethal concentration of penicillin
(22). Persister cells are a distinct phenotypic variant in the bacterial population that
exhibits transient, yet extreme, antibiotic tolerance without undergoing any genetic
modification (22-24).
In In vitro experiments, persisters display a biphasic killing curve as large fraction
of the susceptible cells are rapidly killed on exposure to high concentration of antibiotics
while small proportion survives for extended period forming a characteristic biphasic
killing curve (Fig. 1) (24, 25). Once the antibiotic stress is removed, persisters resume
their growth forming a new population identical to the original population in constituting
genetic diversity (26) and antibiotic tolerant population (27). Persister cells have been
studied in various pathogenic microbes including S. aureus, Escherichia coli,
Mycobacterium tuberculosis, Pseudomonas aeruginosa, Salmonella spp and Candida
albicans (28). Due to their transient insensitivity towards antibiotic and ability to regrow, persister cells can cause the recurrence of infections (29, 30).

4

Figure 1.2 Schematic illustration of antibiotic persistence
(Killing kinetics during treatment with a bactericidal antibiotic. Maisonneuve E and Gerdes K 2014.
Molecular mechanisms underlying bacterial persisters. Cell (25)).

When a bacterial culture is exposed to lethal dose of bactericidal antibiotic, susceptible cells are
killed (green line) but the tolerant persister cells survive for extended period forming a biphasic
killing curve. The persister population shows the slower killing kinetics (red line), whereas more
elevated slope is exhibited by the high persister (hip) mutant (dashed line). Upon removal of the
antibiotic stress, the surviving persister cells resume growth to form new population that is
identical to the initial population demonstrating their significance as the cause for treatment
failures and recurring infection.

Besides, this insensitivity towards the antibiotics benefits bacteria to adapt to a
changing environment subsequently increases the risk of developing antibiotic resistance
during treatment (31). In antibiotic resistance, genetic modifications in bacteria prevent
antibiotics to act on their targets. Whereas, in antibiotic tolerance, decreased metabolic
activity or a non- growing state of persister cells prevent the exploitation of targets by the
antibiotics (24, 32).
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1.2.1 Antibiotic tolerance is a Major Cause of Treatment Failures
In the absence of antibiotic resistance, antibiotic-tolerant persister cells are
believed to be largely responsible for the recalcitrance of bacterial infections leading to
the treatment failures (33), thereby display high clinical significance. Indeed, the clinical
importance of S. aureus persister cells has been increasingly understood, as evidenced
by their reported presence in recurrent infections (33, 34). For instance, cases of
bacteremia relapse, including recurring infections in endocarditis and in lung transplanted patients, were caused by vancomycin-, linezolid-, and daptomycinsusceptible S. aureus (35-37). Similarly, cystic fibrosis cases of P. aeruginosa are
frequently identified as high persister (hip) mutants (38). Moreover, the clinical
significance of S. aureus persister cells was also demonstrated in a chronic mouse
wound infection model, in which these cells could not be eradicated by the
conventional drugs (39, 40). A recent cohort study in cystic fibrosis patients detected
the presence of non- transient hip P. aeruginosa variants that are decisive for the
chronicity of the disease (41). Indeed, persister cells are ubiquitous and have been
studied in multiple bacterial species (42). Antibiotic resistance occurred to be a major
public health problem and therefore, antibiotic discovery until today are focused on
killing the resistant bacterial cells. However, increasing evidences of treatment failures
due to the drug sensitive persisters prompt much needed insight into eradicating an
antibiotic refractory persister population.
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1.2.2 Biofilm Favors the Formation of Persister Cells That Are Difficult to Eradicate
S. aureus is notoriously known to cause hospital device associated biofilm
infections (43) such as endocarditis, bacteremia, osteomyelitis, periodontitis, and chronic
wound infections (44-48). These infections are often refractory to the antibiotic
treatments due to the presence of persister cells (24, 49, 50). Such recalcitrance of S.
aureus infections imposes high socio-economic burden worldwide. S. aureus biofilms are
composed of matrix of extracellular polysaccharides, proteins and DNA from bacteria as
well as host-derived fibrin matrices that provide niches such as low nutrient or oxygen
level and decreased pH (51), imposing a selection pressure for the generation of
metabolically inactive, energy depleted and antibiotic insensitive persister cells (52, 53),
thereby causing recalcitrant infections (39, 50, 54-57). Due to their dispersal
phenomenon, biofilm associated infections also cause metastatic infections (58, 59).
Several approaches have been proposed to effectively kill persisters within S.
aureus biofilms. One mechanism included the use of metabolites that enable potentiation
of aminoglycoside leading to eradication of bacterial biofilms. For instance, addition of
fructose and mannitol enhanced the gentamicin uptake in the bacterial cells via
generation of proton motive force (PMF) and resulted in eradication of S. aureus and E.
coli biofilms respectively in mouse catheter infection model (40). Likewise, L-arginine
was also shown to facilitate biofilm eradication by gentamicin via pH mediated
mechanism in mouse catheter model (60). Another approach in eradicating persisters in
biofilm was demonstrated based on corruption of mechanism that is independent of the
energy requirement. This study used a synthetic acyldepsipeptide antibiotic ADEP4 that
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binds the ClpP protease resulting in degradation of more than 400 proteins. In
combination with rifampicin, ADEP4 was shown to eradicate persister cells in mouse
catheter infection model (39).
1.2.3 Mechanism of Persister Cells Formation is not Well Understood
Despite plethora of studies and history of more than 70 years, mechanism of
persister formation in S. aureus is poorly understood. The involvement of stringent
response and dormancy were widely recognized as underlying factors for bacterial
persistence, however, recent studies as challenged these findings (29, 61-63); persister
switch has been even more an obscure bacterial phenomenon.
Intracellular S. aureus survival is largely considered for the cause of recurrent
infections. However, studies are lacking to understand regulation of persister switch
intracellularly. Nonetheless, a recent study depicts a clinical relevance of treatment
failures of S. aureus infections by demonstrating the occurrence of persister switch
intracellularly in response to an antibiotic stress. Additionally, these persister cells were
shown to be extremely tolerant to other antibiotics and exhibited multiple adaptive
responses against different stresses (64). However, the regulation of the network of these
adaptive responses is not known.
1.2.4 Decreased Metabolism Influences Persister Cells Formation in Bacteria
In recent years, an increasing number of studies have sought to understand the
mechanism of persister formation dependent on the metabolic activities of bacterial cells.
Studies have so far demonstrated an association between the depletion of intracellular
ATP and the formation of persister cells in major bacterial pathogens including S. aureus,
8

E. coli, and P. aeruginosa (65-67). Several studies have examined the contribution of
metabolic genes and cellular ATP levels in the formation of S. aureus persister cells. For
instance, Yee et al. identified the involvement of purine genes in persister cell formation
in the presence of rifampicin (68). Likewise, Wang et al. showed that a mutant of
succinate dehydrogenase (encoded by sdhA/B) is defective in formation of persister cells
against an antibiotic (levofloxacin), heat, and oxidative stresses (69). Similarly,
inactivation of phoU causes deficiency in the persister population due to increased
metabolic activity (70). Recently, inactivation of tricarboxylic acid (TCA) cycle genes
was shown to form drastically increased numbers of persister cells due to reduced ATP
and membrane potential, suggesting the role of metabolism in persister formation (71,
72). This association was also evidenced in polymicrobial cultures in which S. aureus
displayed increased antibiotic tolerance, accompanied by reduced membrane potential
and intracellular ATP concentration (73). The reduced ATP level associated with
increased persister formation was also observed in inactivation of carbamoyl phosphate
synthetase (carB) in the major pathogens S. aureus, E. coli, and P. aeruginosa (67). In
general, it appears that the conditions that reduce intracellular ATP and membrane
potential, as well as cease transcription or translation, dramatically increase antibiotic
tolerance in bacteria (29, 65, 66). Together, these observations strongly suggest that the
cellular metabolism and subsequent energy state of cells determine their switch to the
persister phenotype.
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1.3 Oxidative Stress Response in S. aureus
S. aureus is in a constant challenge of endogenous as well as exogenous oxidative
stress. The incomplete reduction of oxygen during aerobic respiration leads to generation
of reactive oxygen species (ROS) causing endogenous oxidative stress. Whereas, during
infection, S. aureus is challenged by the exogenous oxidative stress that is exerted by the
hostile environment (74) . Host immune cells, such as neutrophils, monocytes, and
macrophages, express NADPH oxidase, which is responsible for generation of the
superoxide anion (O2·−) during oxidative bursts (75), thus exerting the exogenous
oxidative stress to the pathogen. The O2·− is presumed to contribute to bacterial killing
and is involved in an array of chemical reactions that generate ROS including hydroxyl
radicals (OH·), peroxynitrite (ONOO−), and H2O2, which are all highly lethal to bacterial
cells (76). Killing by the host immune cells depends primarily on damaging lipids,
proteins, and DNA of the pathogen. On the other hand, S. aureus has evolved a complex
regulatory network that controls a multitude of defense mechanisms against the
deleterious effects of oxidative stress stimuli.
1.3.1 S. aureus Possess Arrays of Stress Responsive Regulators
The defense systems in S. aureus are required for survival and persistence in its
hosts. The acquisition of antibiotic resistance and/or tolerance and its numerous virulence
factors contribute to the ability of S. aureus to cause variety of infections (33, 77-79). In
addition, this pathogen has acquired the ability to evade or invade the host defense
system to adapt and proliferate inside host immune cells during infectious processes,
leading to persistent infections (11, 80, 81).
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To combat these lethal effects, S. aureus has evolved complex regulatory systems.
These systems include the characteristic golden pigment carotenoid (encoded by
crtOPQMN) (74, 82), catalase (katA) (83, 84), and superoxide dismutases (sodA/M) (8587). In addition, many genes, including those of the PerR regulon (katA, mrgA, zosA, and
ohrA) and the SigB regulon, have been shown to be involved in the response to oxidative
stress (88, 89). S. aureus also possesses several peroxiredoxins, which are induced on
exposure to H2O2 (90, 91). The peroxiredoxins include two enzymatic groups, the alkyl
hydroperoxide reductase (ahpC) family and the osmotically inducible protein/organic
hydroperoxide reductase superfamily associated with detoxification of alkyl and organic
hydroperoxides (92). S. aureus AhpC also confers resistance to a wide spectrum of ROS
(84).
Since oxidative stress imparts deleterious effects to all aspects of physiology,
including the enzymatic activity of bacterial pathogens, the regulation of defensive
systems against these stimuli is complex (74). Alteration of enzymatic activity in turn
changes metabolite concentrations and redox poise. These changes ultimately alter the
activity of redox or metabolite responsive regulators such as CcpA or CodY (93, 94). The
global regulators MgrA, SarZ, and PerR are important S. aureus proteins that are
involved in sensing oxidative stresses (91, 95).
Apart from these responsive systems, the environmental stimuli trigger the
emergence of slow growing mutant population in S. aureus, known as small colony
variants (SCVs) that are often isolated in the clinical samples. Majority of the SCVs have
defective ETC due to the mutation in heme and menaquinone biosynthetic pathways. Due
11

to loss of ETC, the SCV phenotypes are characteristically more resistance towards H2O2
thus confer survival, host cell invasion and persistence causing chronic S. aureus
infections (96). Possession of all these oxidative stress-responsive systems contributes to
the success of S. aureus as a human pathogen capable of causing persistent infections.
1.4 The msaABCR Operon in S. aureus
The msaABCR operon constitutes four-genes (msaA, msaB, msaC and anti-sense
msaR), which was previously characterized by Elasri research group (97). Among these
genes, msaB that encodes MsaB (also known as CspA) is the only protein coding gene
found so far. On the other hand, the msaC, a non-protein coding RNA is found to be
essential to regulate the function of the msaABCR operon. In addition, the anti-sense
msaR, which is complementary to the 5’end of the msaB, expresses differentially
dependent on S. aureus growth phase indicating its possible function as a regulator of the
operon (Fig. 2). In our previous studies, we observed involvement of msaABCR operon in
virulence of S. aureus including biofilm development (97, 98), capsule production (99),
and antibiotic resistance (100, 101). Results from these studies demonstrated msaABCR
(MsaB) as the dual transcriptional regulator in S. aureus.
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Figure 1.4 Schematic representation of the msaABCR Operon
(Map of the msaABCR operon: Sahukhal GS and Elasri MO. 2014. Identification and characterization of an
operon, msaABCR that controls virulence and biofilm development in Staphylococcus aureus. BMC
Microbiology (97)).
Long thin arrows with nucleotides (nt) length represent the corresponding RNAs in the operon identified by
rapid amplification of cDNA ends (RACE) and Northern blot analysis. Short thick arrows indicate the
positions and directions of the gene-specific primers used in the separate reactions.

We identified that the msaABCR operon controls the processing of major
autolysin, Atl by repressing the protease production. Inactivation of the msaABCR led to
increased protease production causing increased processing of Atl and uncontrolled cell
death (autolysis) resulting in defective biofilm in S. aureus (98). In another study, we
identified the msaABCR (MsaB) essential for capsule production in two most significant
capsule serotypes of S. aureus. As evidenced by the decreased cap transcripts and
capsule production in the msaABCR mutants of UAMS-1 and Mu50 strains, and binding
to the cap promoter, MsaB was identified as the DNA-binding transcriptional activator of
cap operon (102). The MsaB activation of cap was found to be in late and stationary
growth phases when the nutrient concentration is decreased. While studying the cap
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regulation in nutrient dependent manner, we observed MsaB interaction with CodY, a
nutrient sensing regulator in S. aureus. CodY activates the production of capsule in
nutrient rich condition. However, as the nutrients are depleted, the conformational
changes in CodY results in its inefficiency in binding cap promoter whereas, MsaB was
found to bind the cap promoter and activate capsule production under these conditions
(99). Additionally, MsaB was also found to regulate codY and ccpE suggesting its
implication in the host-pathogen interaction during disease progression (99).
The inactivation of msaABCR led to decreased cell wall thickness resulting into
increased susceptibility towards vancomycin in vancomycin intermediate S. aureus
strains (VISA) Mu 50, HIP6297 and LIM2, thus suggested that the msaABCR contributes
to the resistance towards vancomycin in S. aureus (100). Furthermore, we observed that
the increased protease activity in the msaABCR mutant resulted into decreased cell wall
cross-linking due to increased murein hydrolase activity. Additionally, the msaABCR
operon was found to play role in the peptidoglycan synthesis as supported by
downregulation of genes in early peptidoglycan synthesis pathway in the msaABCR
mutant (101). In a recent implant associated study in rats, the msaABCR operon was
found to play role in chronic osteomyelitis by regulating extracellular proteases, adhesins
and other virulence factors (103), suggesting that the msaABCR operon is crucial in S.
aureus adaptation in the host.
1.4.1 The msaABCR Operon Functions as a Global Regulator in S. aureus
RNA transcriptomic data of the msaABCR mutant in MRSA USA300 LAC strain
shows differential expression of 287 genes involved in carbohydrate metabolism, stress
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response, and virulence in S. aureus (104). A previous study has also demonstrated MsaB
as a RNA chaperon binding to 213 mRNAs (105). In addition, deletion of MsaB causes
differential expression of 282 functional proteins involved in carbohydrate metabolism,
stress response, cell wall and capsule biosynthesis. These results suggest that MsaB
possibly modulates the functions of proteins as an RNA chaperon (105). All these
findings highlight the importance of msaABCR (MsaB) as a global regulator and a
promising therapeutic target in S. aureus infections.
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CHAPTER II –SIGNIFICANCE, HYPOTHESIS AND INNOVATION
2.1 Significance
The treatment failures of S. aureus systemic infections impose high socioeconomic burden worldwide. Chronic in nature, these infections are difficult to treat by
the traditional drugs. Increasing evidences suggest that the antibiotic tolerant persister
cells are the major cause for the recalcitrance of S. aureus infections. Despite more than
70 years of history and plethora of studies, the mechanism underlying persister cells
formation is not yet conclusive. In this study, we studied the involvement of the
msaABCR operon in persister cells formation and stress response in S. aureus, and
deciphered the regulatory role of the operon in these phenomena. The role of msaABCR
in persister formation is novel and understanding this mechanism would have significant
impact in designing novel therapeutics that consequently would help minimize the
treatment failures of staphylococcal infections.
2.2 Hypothesis
Recently, studies have demonstrated the causal link of decreased cellular energy
state and increased antibiotic tolerance in S. aureus (65, 71-73). Considering this
association, the differential expression of genes of metabolism and stress response in the
msaABCR mutant as compared to the wild type USA300 LAC transcriptomics led us to
hypothesize that the msaABCR operon regulates the response against stresses exerted by
the antibiotics or the host environment during infections. In this study, we tested these
hypotheses by pursuing following specific aims:
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Specific Aim 1: Study the involvement of msaABCR operon in persister formation
in S. aureus. The frequency of persister formation depends on the growth conditions of
the bacterial cultures such that it increases as the cells enter to the stationary growth
phase. Likewise, Biofilms are referred to as the favorable niche for the generation of
extremely tolerant persister cells due to their stressful environment. Considering the
importance of growth phase or condition in the generation of persister cells, we tested the
persister fraction in both planktonic (exponential, mid-exponential and stationary growth
phase) as well as in biofilms in the presence of clinically relevant of antibiotics belonging
to different classes. Moreover, this experimental approach would also lead us to
understand whether the role of the msaABCR operon is growth phase or stress dependent.
Specific Aim 2. Study the msaABCR regulation of metabolism and its association
with antibiotic tolerance in S. aureus. Given the importance of increased metabolic
activities in reducing antibiotic tolerance, first, we tested the impact of the msaABCR
operon in cellular energy state of S. aureus in different growth phases. Further, we
examined the mechanism underlying regulation of metabolism by the msaABCR operon
and its association with the antibiotic tolerance in S. aureus.
Specific Aim 3. Study the regulatory role of the msaABCR operon in stress
response and intracellular persistence/survival. To withstand the environmental cues, the
pathogens must develop adaptive responses. Previous studies along with our findings
indicate that msaABCR (MsaB) is a global modulator of gene expression (99, 104-106).
Since the deletion of the msaABCR operon showed differential expression of the genes
involved in metabolism as well as oxidative stress response in S. aureus (104), we
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speculated that the msaABCR operon regulates the response against environmental stress
during infection. In this study, we specifically examined the msaABCR regulation of
response against oxidative stress in S. aureus.
2.3 Innovation
Understanding the mechanism of persister cells formation has been a puzzling
problem particularly due to their transiency and small population size. Deletion of the
msaABCR operon resulted in diminished number of persister cells in both planktonic as
well as biofilm growth conditions, indicating the possibility that inactivation of the
operon overcomes treatment failure of S. aureus infections that is associated with
antibiotic persistence/tolerance. The study model proposed in this project deciphers the
mechanism of antibiotic as well as intracellular persistence of an important human
pathogen S. aureus. Identification of the regulatory determinants in persister switch is an
aspect of S. aureus infections, which is not known. This project is innovative in that it is
exploring the role the msaABCR operon, a global regulator in S. aureus in antibiotic as
well as intracellular persistence. The findings from this study suggested that the
msaABCR could be a potential target to overcome the heightened issues of therapeutic
failures of S. aureus infections.
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CHAPTER III –EXPERIMENTAL APPROACHES
3.1 Bacterial Strains and Growth Conditions
Methicillin-resistant S. aureus (MRSA) USA300 LAC, methicillin sensitive S.
aureus (MSSA) UAMS-1, isogenic msaABCR operon mutant (msaABCR), and
complementation strains were used. Bacterial pre-cultures were prepared by inoculating
cells from frozen culture into 5 ml of freshly prepared Muller Hinton Broth (MHB) or
tryptic soy broth (TSB; Becton, Dickinson and Company, MD, USA) or chemically
defined medium (CDM) as previously described (99). All cultures were incubated at 37°C
with continuous shaking at 225 rpm. The stationary-phase cultures were grown for 24 h
unless otherwise stated. E. coli strain DH5α and the restriction-deficient S.
aureus laboratory strain RN4220 were used to move plasmid constructs into the strains of
choice through transformation and phage transduction.
3.2 Generation of Transposon Mutants and Complementation
The transposon mutants used in this study were generated as previously described
(99, 106). Briefly, a plasmid-cured derivative of LAC strain JE2 containing the
transposon mutation within the coding regions of the corresponding genes was obtained
from the Network on Antimicrobial Resistance in the S. aureus (NARSA) collection (Bei
Resources). The mutation was then transduced into either USA300 LAC or UAMS-1
strain by generalized transduction using bacteriophage φ11. The transduction of the
mutation into the recipient strains was confirmed by amplifying the beginning and end of
the open reading frame (ORF) of the corresponding genes, as previously described (99,
106, 107). The allelic replacement method was used to generate the msaABCR operon
19

deletion in the strains USA300 LAC and UAMS-1, as previously described (32, 44). For
trans-complementation, the ORF of msaABCR region was cloned into the pCN34 lowcopy-number vector with the modification of changing the kanamycin selectable marker
to a chloramphenicol resistance marker.
3.3 Persister Assays
3.3.1 Persister Assays in Planktonic Cells
Frozen S. aureus cells were inoculated in fresh MHB or TSB and grown for ~3
hours. These pre-cultures were normalized to an OD600 nm of 0.05 in 5 ml TSB at a flaskto-medium ratio of 10:1 and incubated at 37°C until the required growth phase:
Exponential (OD600 nm of 0.5-0.7), mid-exponential (OD600 nm of ~4.0) and stationaryphase (16 or 24 h). For persister measurement in exponential growth phase, first, 100 μl
of culture in MHB was removed, serially diluted in 900 μl of 1 × phosphate buffer saline
(PBS) and plated for colony forming units (CFUs) for the initial count. The remaining
cultures were individually challenged with daptomycin (10 μg/ml, 10 × MIC)
supplemented with 50 mM calcium chloride (CaCl2), vancomycin (25 μg/ml, 40 × MIC),
linezolid (50 μg/ml, 10 × MIC), rifampicin (2.4 μg/ml, 40 × MIC), and gentamicin
(20 μg/ml, 20 × MIC) and further incubated at 37 °C with continuous shaking. We used
the minimum concentration of each antibiotic that showed similar killing kinetics to that
of higher concentrations of the respective antibiotic. At designated time points of
antibiotic exposure, 100-μl of aliquot was removed, washed with 900 μl of 1× PBS and
plated for the CFUs count after 24 h of incubation. When the culture reached stationaryphase (16 or 24 h), 100-μl aliquot was used to count the initial CFUs while the remaining
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culture was challenged with antibiotics daptomycin (80 μg/ml, 80 × MIC) with 50 mM
CaCl2, vancomycin (125 μg/ml, 200 × MIC), linezolid (100 μg/ml, 20 × MIC), rifampicin
(4.8 μg/ml, 80 × MIC), gentamicin (20 μg/ml, 20 × MIC) and tobramycin (20 μg/ml, 20 ×
MIC). Likewise, to measure the persister frequency in mid-exponential phase, first, 100μl aliquots were diluted in PBS and plated for the initial CFU counting, whereas 3 ml of
the culture was individually challenged with gentamicin (20 μg/ml, 20 × MIC),
vancomycin (62.5 μg/ml, 100 × MIC), ciprofloxacin (250 μg/ml, 100 × MIC), or
tobramycin (20 μg/ml, 20 × MIC) and incubated further. At the designated time post
exposure, 100 μl of culture was removed, washed with PBS, diluted, and plated for CFU
counting.
For the persister assay in the presence of arsenate and carbonyl cyanide mchlorophenyl hydrazone (CCCP), stationary-phase cells were challenged with arsenate (1
mM) and different concentrations of CCCP (0.001–10 μM) for 30 min prior to the
addition of gentamicin. At 24 h post exposure, the cells from 100-μl aliquot were
harvested, washed, and plated for CFU counting.
3.3.2 Persister Assays on Catheter Based Biofilms
To measure persister in catheter based biofilms, 1-cm-long sterile catheters
(fluorinated ethylene propylene, BD Infusion Therapy System Inc., UT) were incubated
with 20% human plasma (Sigma-Aldrich, MO) overnight in 24-well microtiter plates.
After plasma coating, the catheters were incubated with S. aureus cells (OD600 of 0.05) in
biofilm medium (TSB + 0.5% glucose + 3% NaCl) for 24 h with continuous shaking.
After incubation, the catheters were removed, washed gently with PBS to remove the
21

non-adherent S. aureus cells, and sonicated for initial CFU counting. The remaining
catheters were treated with antibiotics and further incubated at 37°C. Each day after
treatment, the catheters (n=3) were recovered, and the spent medium was replaced with
fresh biofilm medium (500 μl) with the corresponding antibiotics. The catheters were
gently rinsed in PBS to remove any non-adherent bacteria, placed in glass tubes, and
sonicated to recover the adherent S. aureus cells. The recovered CFUs were counted for
all three catheters. This procedure was continued for 4 days. All experiments were
performed in triplicate and repeated twice.
3.4 RNA Extraction, Reverse Transcription, and qRT-PCR
Aliquots of 500 μl from the required growth cultures were treated with equal
volumes of RNAprotect bacterial reagent (Qiagen, Valencia, CA) for 5 min at room
temperature. Total RNA was extracted using the Qiagen RNeasy kit (Qiagen), and the
quality and concentration of the extracted RNA were analyzed using a NanoDrop
spectrophotometer (Thermo Scientific). Reverse transcription was performed with the
iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA) using 1 μg of the total
RNA isolated according to the manufacturer’s instruction. Next, qRT-PCR was
performed using SYBR Green supermix (Bio-Rad), and the relative fold change in gene
expression was calculated using gyrB as an endogenous control gene. The data represent
the results from three independent experiments. Primers used in this study are listed in
Table 4.13.
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3.5 Measurement of ATP
Intracellular ATP content was measured using the BacTiter-Glo™ kit (Promega,
WI, USA) according to the manufacturer’s instruction. Briefly, cells grown to the
required phase were adjusted to an OD600 nm of 0.025 in 1 ml of TSB, from which 50 μl
were dispensed into wells of an opaque 96-well plate, followed by the addition of an
equal volume of BacTiter-Glo™ Reagent. The luminescence was measured at OD560 nm
after 5 min of incubation at room temperature.
3.6 Measurement of NAD+/NADH Content
Overnight cultures were diluted to an OD600 of 0.05 and grown until late
exponential-phase (OD600 of 4.0). Cells were harvested and washed twice with ice-cold
PBS, and NADH levels were measured according to the manufacturer’s instructions
(NAD+/NADH quantitation kit, Sigma-Aldrich). Values represent the absolute
concentrations of NAD+ and NADH per μg of protein.
3.7 Measurement of Membrane Potential
Membrane potential was assessed using the BacLight™ Bacterial Membrane
Potential kit (Life Technologies, USA). Stationary-phase cells were washed and
resuspended with 0.5 ml of filtered PBS (2 × 107 cells). Next, 16.6 µl of the fluorescent
membrane potential indicator dye 3, 3′-diethyloxacarbocyanine iodide (DiOC2(3)) was
added and incubated at room temperature for 30 min. The fluorescent signals of 100,000
cells were recorded using a Fortressa flow cytometer (BD Biosciences, CA, USA).
Negative control cells were incubated with 10 μM CCCP for 30 min prior to adding
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DiOC2(3). The ratio between red fluorescence (PE-A) and green fluorescence (FITC) was
calculated and analyzed with FlowJo v10 software.
3.8 Expression and Purification of MsaB
The MsaB protein was expressed in msaABCR mutant of USA300 LAC strain.
The primers UpA, UpB, DnC, and DnD listed in Table 4.13 were used to label MsaB
protein with 6 × His at the C-terminal end (MsaB-His). To generate the expression
construct, the ORF of msaB was PCR amplified using primers listed in Table 4.13 and
cloned into the inducible plasmid pCN51using the BamHI and EcoRI restriction
enzymes. The plasmid construct was then transformed into E. coli strain DH5α. The
plasmid isolated from transformed DH5α cells was used to transduce the restriction-less
S. aureus RN4220 competent cells. The plasmid was then moved to USA300 LAC
msaABCR mutant through generalized transduction using bacteriophage φ11.Protein
expression was induced by adding 10 μM cadmium chloride (CdCl2) at exponential-phase
and incubating further with shaking. The cells were pelleted after 4 h of induction,
resuspended in PBS (pH 7.4) with a protease inhibitor cocktail, and then lysed by bead
beating followed by sonication. The cell lysate was centrifuged at 10,000 × g for 30 min
to remove the cell debris. The 6 × His-MsaB fusion protein was purified from the clear
lysate with a nickel column (HisPur Ni-nitrilotriacetic acid [Ni-NTA] resin; Thermo
Scientific).
3.9 Chromatin Immunoprecipitation (ChIP) Assay
The ChIP assay was performed as described by Sengupta et al. (108), with slight
modifications adopted in our lab (102). Briefly, S. aureus cells in stationary growth phase
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were treated with 1% formaldehyde and 10 mM sodium phosphate to facilitate the crosslinking of MsaB to its targets. After 20 min, the cross-linking reaction was quenched by
the addition of 0.1 volumes of 3 M glycine. The cultures were then pelleted and washed
with an equal volume of 0.1 M phosphate buffer to remove excess formaldehyde. The
phosphate buffer was removed by centrifugation, and the cells were resuspended in
600 μl IP buffer (50 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 5
% (v/v) glycerol, 1% Triton X-100) and lysed with a bead beater. The 400-μl cell lysates
were then sheared by sonication to obtain fragment sizes of ~500 bp. The clear
supernatant obtained after brief centrifugation was diluted with 1 ml IP buffer, and an
anti-MsaB antibody (diluted 1: 1000) was added and incubated at room temperature for 2
h with gentle shaking. This antigen–antibody mixture was then added to prewashed
protein G-coupled magnetic beads (Thermo Scientific) and incubated further for 1 h as
above. The antigen–antibody–bead complex was collected with a magnetic tube holder,
washed five times with wash buffer (Tris-buffered saline, 0.05 % Tween 20, 0.5 M
NaCl), followed by washing once with ultrapure water. The beads were then resuspended
in 100 μl elution buffer (0.1 mM glycine, pH 2.0) and neutralized with neutralization
buffer (Tris-EDTA, pH 8.0), followed by incubation at 65 °C overnight to reverse the
cross-links (decoupling). The DNA extracted with the phenol–chloroform extraction
method was used as the template to detect the MsaB-bound promoter sequences with
PCR amplification using promoter-specific primers. The msaABCR mutant was used as
an internal negative control to demonstrate that the MsaB antibody is specifically
enriched in the promoter regions. Primers used in this assay are listed in Table 4.13.
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3.10 Electrophoretic Mobility Shift Assay (EMSA)
Electrophoretic mobility shift assays were performed using the LightShift™
optimization and control kit (Thermo Scientific) according to the manufacturer's protocol.
Briefly, the binding reaction mixture was prepared with ultrapure water containing 1×
binding buffer, 50 ng poly (dI-dC), 2.5% (v/v) glycerol, 0.05% (v/v) NP-40, and 5 mM
MgCl2. Biotin-labeled probes for ndh2, ccpE and gudB genes (listed in Table 4.13) in the
appropriate concentrations were incubated with increasing concentrations of purified
recombinant MsaB–His protein in the binding reaction buffer and unlabeled specific
probe when required. The mixture was then incubated at room temperature for 25 min
and subjected to electrophoresis at 100 V for 1 h in a pre-run 5% Tris-borate EDTA
(TBE) gel. The samples were then transferred to a nylon membrane, incubated for 45 min
in the cold, crosslinked, and processed for the detection of samples. The protein–DNA
complexes in the gel were then visualized using the Chemiluminescent EMSA kit
(Thermo Scientific) according to the manufacturer's protocol and imaged with a
ChemiDoc system (Bio-Rad). Probes used in this assay are listed in Table 4.13.
3.11 Gentamicin Uptake Assay
Gentamicin–Texas Red conjugate (Gent :: TR) was prepared as previously
described (109) with slight modifications. Briefly, 440 µl of 50 mg/ml gentamicin sulfate
was mixed with 60 µl of 2 mg/ml amine-reactive Texas Red-X succinimidyl ester
(Invitrogen) in anhydrous N, N-dimethylformamide. The mixture was gently rotated for 3
days at 4°C to produce an approximately 30: 1 molar ratio (~10 mM gentamicin and 0.3
mM Texas Red reagent) of Gen :: TR. Next, 100 μl of the Gen :: TR was added to the
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stationary-phase cells (2 × 107), washed, and resuspended in 2 ml PBS for 3 h at 37°C
with continuous rotation. After incubation, the cells were washed twice, resuspended in
500 μl PBS, and evaluated by flow cytometry with excitation/emission maxima at
595/615 nm.
3.12 In vitro Oxidative Stress Assays
The stationary-phase cells prepared as above were washed, and diluted to an
OD600 nm of 0.1 in 1 ml PBS and containing 34 mM H2O2 and incubated for 1 h. After
incubation, catalase (2,000 U/ml) was added and incubated for 1 min at room temperature
to decompose the remaining H2O2. The cells were diluted and plated to obtain the CFUs
count. The survival percentage represents the percentage of initial CFUs that survived the
H2O2 treatment after 1 h. Similarly, the cells prepared as described above were stressed
with 25 mM H2O2 in 5 ml of TSB, and growth was monitored by CFUs count at
designated time points. A detection limit of 100 CFU/ml was established for the results
that showed ≤102/ml in undiluted culture treated with H2O2. For organic hydroperoxide
assays, cells were prepared as described above, washed with PBS, and diluted to an
OD600 of 6.0 for all strains tested. The cells were then serially diluted (up to 10–8), and 10
μl of each dilution was pipetted onto tryptic soy agar (TSA) plates containing 5 mM tertbutyl hydrogen peroxide (tBOOH) and 4 mM cumene hydrogen peroxide (CHP) to obtain
the CFUs count after 24 h incubation.
3.13 Construction of Fsmut-msaB
We used an overlap extension PCR cloning technique to generate a frameshift
mutation in msaB ORF. The upper 706-bp fragment of msaABCR operon was PCR
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amplified by using primer set Fsmut-msaB F1 and Fsmut-msaB R1, and the lower 1,090bp fragment of msaABCR operon region was amplified using primer set Fsmut-msaB F2
and Fsmut-msaB R2. Primers Fsmut-msaB R1 and Fsmut-msaB F2 overlap, such that an
insertion of one nucleotide causes a frameshift mutation in msaB. Both the PCR
fragments were PCR purified using a Promega DNA cleanup kit, and 50 ng of each
fragment was used in the PCR ligation, which contained all the ingredients of the PCR
mix except the terminal primers (Fsmut-msaB F1 and Fsmut-msaB R2). The PCR cycle
was carried out for 15 cycles, and finally, the terminal primers were added to the reaction
mixture and PCR was run for 20 additional cycles. The amplified PCR product was
ligated with the pCN34 low-copy-number plasmid vector, and then transduced into the
msaABCR mutant using bacteriophage φ11. The FSmut-msaB construct was verified by
sequencing. Primers used in this experiment are listed in Table 4.13.
3.14 Overexpression of the ohr Gene
To generate the overexpression construct, the ohr gene was PCR amplified using
primers listed in Table 4.13, and cloned into the inducible plasmid pCN51 using the
BamHI and EcoRI restriction enzymes. The plasmid construct was then transformed into
E. coli strain DH5α. The plasmid was then isolated from transformed DH5α cells and
used to transduce the restriction-less S. aureus RN4220 competent cells. The plasmid was
moved to the msaABCR mutants (msaABCR :: POhr) through generalized transduction
using bacteriophage ϕ11, as described previously (100). The overexpression of the gene
was analyzed with qRT-PCR by adding CdCl2 (10 nM to 1 μM) in the exponential growth
phase. Induction with the 100 nM CdCl2 concentration overexpressed the gene by 5- to
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10-fold, while use of different concentration (higher or lower), the expression level of ohr
was lowered. Therefore, we chose this concentration for the induction. When preparing
msaABCR :: POhr cells for the oxidative stress assay, cells were induced by adding
100 nM CdCl2 in the early (2 h), late and post-exponential (4 h and 12 h) growth phases
of culture.
3.15 Extraction of Staphyloxanthin
Staphyloxanthin (STX) was extracted using the methanol extraction method as
described previously (97). Briefly, cells grown overnight were normalized to an OD600 of
0.05 in 10 ml of TSB and cultured for 16 h at 37°C with continuous shaking. Cells were
harvested, washed twice with deionized water, and pelleted after normalizing all the
strains to an OD600 of 10.0 in 1 ml. Then, the cells were mixed with 1 ml of methanol and
incubated in a 58°C water bath for 10 min with occasional vortexing. The supernatant
was harvested by centrifugation at 16,000 × g for 1 min, and the absorbance of STX was
measured at OD465, with methanol as a blank.
3.16 Macrophage Survival Assay
Macrophages (RAW 264.7) were prepared by growing in Cyto 6-well plates in
sterile RPMI 1640 medium at 37°C supplemented with CO2. Stationary-phase S. aureus
cells were harvested, washed, and diluted in PBS. The bacterial cells (2 × 105 CFUs) with
a multiplicity of infection (MOI) of 10 were incubated with macrophages at 37°C
supplemented with CO2. At a designated time, gentamicin 200 μg/ml was added to each
well for 20 min to kill extracellular bacterial cells. The content of each well was gently
removed and washed 3 times with PBS, and finally, 1 ml ice-cold deionized water was
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added to rupture the macrophages. The released bacterial cells were serially diluted and
plated on Columbia agar to determine the intracellularly surviving CFUs count after
incubation at 37°C for 24 h.
3.17 In vitro Whole-Blood and Neutrophil Survival Assay
The survival of S. aureus in whole human blood was measured in vitro. In brief,
heparinized venous blood samples were collected from healthy donors according to a
protocol approved by the Institutional Review Board (IRB) for Human Subjects at the
University of Southern Mississippi. S. aureus cells were harvested in the post
exponential-phase of growth. The blood samples (3 ml) were inoculated with 3 ×105 S.
aureus cells in a 14-ml culture tube and incubated at 37°C for 2 h with end-over-end
rotation at 20 rpm. The samples were then diluted with sterile deionized water to lyse the
blood cells, and the number of CFU was determined after plating on TSA plates. The
neutrophil survival of S. aureus was measured using freshly isolated human polymorphic
neutrophils (PMNs). In brief, PMNs (1×106) were combined with S. aureus (1×107) in a
24-well tissue culture plate and centrifuged at 380 × g for 8 min. The CFUs were then
incubated for 2 h at 37°C with 5 % CO2. After incubating, the neutrophils were lysed
using deionized water, plated on TSA plates, and incubated overnight at 37°C. The CFUs
were counted, and the test samples were compared with controls, which contained
deionized water instead of the neutrophil suspension. This assay measures the total
number of viable bacteria.
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3.18 Statistical Analysis
All data were analyzed using OriginPro (2017) software using student’s t-test
(unpaired) or one-way analysis of variance (ANOVA) followed by Tukey’s multiple
comparison test, with p<0.05 considered as statistically significant.
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CHAPTER IV –RESULTS
4.1 The msaABCR Mutant Exhibits Similar Growth Kinetics and the Antibiotic
Susceptibility as Wild Type USA300 LAC
Prior to conducting persister assays, we examined the growth kinetics, and MIC
values of our test strains (wild type USA300 LAC, isogenic msaABCR mutant and its
complementation). In the nutrient rich medium MHB or TSB, there was no observable
growth defect in the msaABCR deletion mutant in both exponential and stationary growth
phase as compared to the wild type USA300 LAC (Fig. 4.1A, B).
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Figure 4.1 Measurements of growth kinetics
(A) Growth rate measurement in nutrient rich MHB medium during the exponential-phase of growth. (B)
Growth rate in the stationary-phase of growth. Data represents the number of CFUs at the designated time
points. Error bars represent standard error (SE).

Considering the clinical significance of antibiotic tolerance, in this study, we
measured the persister frequency against antibiotics daptomycin, vancomycin, linezolid,
rifampicin and gentamicin that are commonly used to treat serious MRSA infections as
discussed in the Clinical Practice Guidelines by the Infectious Diseases Society of
32

America (110). To determine the MIC values of these antibiotics, standard micro-broth
dilution method was followed and their susceptibility was defined based on the Clinical
Laboratory and Standards Institute (CLSI) guidelines (111). Deletion of the msaABCR
operon did not change the susceptibility of S. aureus towards daptomycin, linezolid, or
gentamicin. Whereas, it showed two-fold decrease in MIC values of rifampicin and
vancomycin as compared to the wild type USA300 LAC (Table 4.1).
Determination of minimum inhibitory concentration (MIC) values of antibiotics
Antibiotics
Daptomycin
Rifampicin
Vancomycin
Linezolid
Gentamicin
Tobramycin
Ciprofloxacin

Minimum Inhibitory Concentration (μg/ml)
USA300 LAC
1
0.06
0.625
5
1
1
2.5

msaABCR
1
0.0312
0.312
5
1
1
2.5

Complementation
1
0.06
0.625
5
1
1
2.5

These selection criteria including similar growth rate, and susceptibility of our test
strains, ruled out the possibility that the growth defects or the increased drug resistance
were responsible for the corresponding persister frequency in our test strains.
4.2 Role of the msaABCR Operon in Persister Cells Formation
During exponential growth of bacteria, persisters are developed at low
frequencies, which increase drastically upon entering the stationary growth phase (24, 32,
65). Indeed, almost all stationary-phase S. aureus cells are tolerant towards the
conventional drugs, behaving as persister cells because of their characteristic slow- and
non-growing phenotype (33, 65). Likewise, biofilms harbor extremely tolerant persister
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population due to their stressful environment resulting through depletion of nutrients and
oxygen level (50, 52). Therefore, in this study, first, we sought to examine whether the
impact of the msaABCR operon in persister cell formation is dependent on growth phases
or conditions (exponential, stationary, and biofilm) and the antibiotic stress. In these
assays, we observed different trajectories of killing curves corresponding to the antibiotic
treatment and the growth conditions of our test strains. To confirm whether the surviving
cells were persister cells, first, we conducted retreatment experiment in which the
persister cells grown in fresh medium were exposed to the antibiotic for four consecutive
cycles. These successive exposures resulted in similar trajectories and frequencies of
surviving population confirming that the surviving cells were the persister cells rather
than the resistant cells (Fig. 4.2).
8
7
6
5
4
3

Figure 4.2 Re-treatment assays
The persister cells retrieved from the vancomycin exposure were grown in fresh MHB medium and treated
with vancomycin, and the persister population was measured in designated time points. This experiment
was repeated consecutively for four cycles. Values represent the results from three independent
experiments. Student’s t-test was used to compare the results of the mutant to wild type strain at
corresponding time point. RT, re-treatment; **, P <0.005.
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4.2.1 Inactivation of the msaABCR Operon Decreases Persister Cells Formation in
the Exponential Growth Phase
The msaABCR mutant was defective in persister cells in most of the antibiotics
tested during the exponential-phase. Daptomycin rapidly killed majority of all the cells
tested within 2 h of treatment. The persister plateau was observed in USA300 LAC and
the complementation strains after 6 h post treatment till 24 h, however no visible CFUs
were detected in the msaABCR mutant post 2 h treatment, demonstrating a failure of
persister formation by the msaABCR mutant in the presence of daptomycin (Fig. 4.2.1B).
Likewise, the number of persister cells in the msaABCR mutant was decreased by
23-fold relative to the wild type USA300 LAC within 48 h of vancomycin treatment
while 55-fold reduced persister cells were observed with rifampicin treatment for 16 h
(Fig. 4.2.1C, E). But, the msaABCR mutant formed similar proportion of persister cells as
that of wild type on exposure to linezolid for upto 72 h (Fig. 4.2.1D). Whereas,
gentamicin showed the highest killing rate forming a persister plateau from 2 to 6 h post
exposure, with 12.5-fold reduced persister cells in the msaABCR mutant compared to
USA300 LAC (Fig. 4.2.1F).
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Figure 4.2.1 Persister assay in the exponential growth phase
Exponentially grown cells were exposed to the antibiotics and persister population was measured at
designated time points. (A) No antibiotic control. (B) Daptomycin (10 μg/ml, 10 × MIC) treatment.
(C) Vancomycin (25 μg/ml, 40 × MIC) treatment. (D) Linezolid (50 μg/ml, 10 × MIC)
treatment. (E) Rifampicin (2.4 μg/ml, 40 × MIC) treatment. (F) Gentamicin (20 μg/ml, 20 × MIC)
treatment. Persister population was measured at designated time points post antibiotic exposure. Time 0 h
represents the antibiotic exposure initiation point. The results represent the means of three independent
experiments. Error bars represent SE. Student’s t-test was used to compare the results of the msaABCR
mutant to wild type at corresponding time point. **, P < 0.005.
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4.2.2 Stationary-Phase msaABCR Mutant is Defective in Persister Cells Formation
in Gentamicin Stress
In the stationary growth phase, daptomycin although killed fraction of cells, there
was no observable difference in the persister population between the wild type and the
msaABCR mutant (Fig 4.2.2B).
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Figure 4.2.2 Persister assay in the stationary growth phase
S. aureus cells grown for 16 h in MHB were exposed to the antibiotics and persister population was
measured at designated time points. (A) No antibiotic control. (B) Daptomycin (80 × MIC) treatment. (C)
Vancomycin (200 × MIC) treatment. (D) Linezolid (20 × MIC) treatment. (E) Rifampicin (80 × MIC)
treatment. (F) Gentamicin (25 × MIC) treatment. The results represent the means of three independent
experiments. Error bars represent SE. Student’s t-test was used to compare the results of the wild type to
mutants at corresponding time point. **, P < 0.005.
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Likewise, we observed similar extent of tolerance towards vancomycin, and
rifampicin in both strains (Fig. 4.2.2C, E). In contrary, the stationary-phase msaABCR
mutant formed 44.67-fold less persister cells relative to USA300 LAC at 72 h post
exposure with linezolid (Fig. 4.2.2D). Interestingly, gentamicin rapidly killed stationaryphase msaABCR mutant cells within 12 h post treatment, resulting into 1.72 ×104-fold
reduced persister cells relative to USA300 LAC. While, no detectable CFUs were
observed in the msaABCR mutant after 24 h, ~5 log CFUs were observed in the wild type
until 48 h post gentamicin treatment (Fig. 4.2.2F).
4.2.3 The Role of the msaABCR in Tolerance towards Aminoglycoside is Specific
and Independent of the S. aureus Strains
To further confirm the necessity of the msaABCR operon in tolerance towards
aminoglycoside stress in the stationary-phase, we measured the persister frequency in
24 h cultures in TSB in the presence of gentamicin. In this assay too, the msaABCR
mutant failed to form persisters, while a fraction of persisters was detected in the
USA300 LAC and complementation strains for a prolonged period, displaying biphasic
Killing curves (Fig. 4.2.3.1A, B). We also measured the persister fraction in the presence
of another aminoglycoside antibiotic, tobramycin, in stationary-phase and biofilm growth
conditions. Again, under both growth conditions, the msaABCR mutant formed
significantly fewer persister cells than the USA300 LAC and complementation strains
(Fig. 4.2.3.1C–F).
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Figure 4.2.3.1 Measurement of persister fraction in the presence of aminoglycosides
(A, C, and E) The killing of USA300 LAC, isogenic msaABCR mutant, and complementation cells in the
presence of antibiotics at the indicated time points. Strains grown to stationary-phase in TSB were exposed
to gentamicin (20 × MIC) and tobramycin (20 × MIC) and biofilms to tobramycin (20 × MIC). (B, D, and
F) Bar graph showing the percentage survival of all test strains at the endpoint of each treatment. (A and B)
Gentamicin treatment. (C and D) Tobramycin treatment in stationary-phase culture. (E and F) Tobramycin
treatment on catheter biofilms. Error bars indicate standard error of the mean (SEM) of at least three
independent experiments. Statistical significance was determined using ANOVA followed by Tukey’s
multiple comparison tests. **, P < 0.001; ***, P < 0.0005; ****, P < 0.0001.
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Figure 4.2.3.2 Antibiotic stress and strain dependent role of the msaABCR in persister
formation
(A and B) The killing of stationary-phase USA300 LAC, isogenic msaABCR mutant, and complementation
cells in the presence of antibiotics at the indicated time points. Strains grown to stationary-phase in TSB
were exposed to antibiotics. (A) Vancomycin (200 × MIC) treatment. (B) Ciprofloxacin (200 × MIC)
treatment. (C) The killing of standardized stationary state UAMS-1, isogenic msaABCR mutant and the
complementation cells in the presence of gentamicin (20 × MIC). (D) Bar graph showing the percentage
survival at the endpoint of gentamicin treatment. Error bars indicate SEM of at least three independent
experiments. Statistical significance was determined using ANOVA followed by Tukey’s multiple
comparison tests. **, P < 0.001.

By contrast, the stationary-phase msaABCR mutant and USA300 LAC strains
formed similar fractions of persister cells in the presence of vancomycin and
ciprofloxacin (Fig. 4.2.3.2A, B), suggesting that the role of the msaABCR in persister
formation is specific to the aminoglycoside stress. To examine whether the role of the
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msaABCR operon is strain dependent, we further examined the persister fraction MSSA
strain UAMS-1. In this strain background too, the msaABCR mutant formed decreased
persister cells indicating that the involvement of the msaABCR operon in aminoglycoside
tolerance is independent of the S. aureus strain (Fig. 4.2.3.2C, D).
4.2.4 The Biofilms of msaABCR Mutant Exhibits Decreased Persister Tolerance
Biofilms provide the source of extremely tolerant persister cells (24, 33, 39, 52).
In our previous study, although early stages (attachment and accumulation) of biofilm
were observed to a similar extent, mature biofilm of the msaABCR mutant was
substantially weaker and loose in comparison to the robust biofilm of the wild type
USA300 LAC (98). Therefore, we speculated less persister cells formation in the biofilms
of msaABCR mutant. To test this, we measured the rate of persister cells formation in
intravenous catheter based biofilm conditions. First, we assessed the biofilm formation by
USA300 LAC, msaABCR deletion mutant and the complementation strains on the
intravenous catheters for four days without antibiotic treatment. We observed that
the msaABCR mutant formed 2.3-fold reduced biofilm (2.13 × 108 CFUs) relative to the
USA300 LAC (4.89 × 108 CFUs) (Fig. 4.2.4A). When challenged with the antibiotics, we
observed pronounced biphasic killing curves in all strains, except for rifampicin, in which
the S. aureus cells showed adaptive resistance after one day post exposure of rifampicin
(Fig. 4.2.4D). The biofilms of msaABCR mutant formed significantly less persister cells
in the presence of daptomycin, linezolid, and vancomycin. Interestingly, the biofilms of
msaABCR mutant was eradicated by gentamicin within day 2, while the wild type
persisted until day 3 (Fig. 4.2.4F).
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Figure 4.2.4 Persister assay in biofilms
Biofilms formed on intravenous catheters for 24 h were exposed to the antibiotics and persister population
was measured at designated time points. (A) No antibiotic control. (B) Daptomycin (20 × MIC) treatment.
(C) Vancomycin (20 × MIC) treatment. (D) Rifampicin (80 × MIC) treatment. (E) Linezolid (20 × MIC)
treatment. (F) Gentamicin (20 × MIC) treatment. The results represent the means of three independent
experiments. Error bars represent SE. Student’s t-test and one way ANOVA followed by Tukey’s test was
used to compare the results of the mutant to wild type at corresponding time points. *, P < 0.05; **, P <
0.001.
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4.3 The msaABCR Mutant Shows Increased Expression of TCA Cycle Genes,
Higher ATP and NADH Content
Persister cell formation in a growing staphylococcal population is associated with
low cellular energy levels (65-67), accompanied by low levels of expression of TCA
enzymes (72). Therefore, we hypothesized that the deletion of the msaABCR operon in S.
aureus cells would result in increased metabolic activity, thus inducing a higher energy
state that prevents persister cell formation. To test this prediction, we first measured the
expression of TCA genes and ATP levels in our test strains. In S. aureus, the TCA cycle
is activated during late exponential growth phase to generate ATP when glucose is
exhausted (112, 113). We examined TCA cycle activity by measuring the expression of
TCA genes (gltA, acnA, icd, sucA, sucD, sdhA/B, and fumC) in late exponential growth
phase via quantitative real-time PCR (qRT-PCR). As expected, we found transcriptional
upregulation of all the TCA genes in the msaABCR mutant compared with the USA300
LAC strain (Fig. 4.3A). Likewise, the msaABCR mutant exhibited higher ATP levels
relative to the USA300 LAC strain in the late-exponential growth phase (4.3B) and
stationary growth phase (Fig. 4.3C). Considering that the TCA cycle provides reduced
dinucleotides, we measured NADH content in our strains, and the results showed
significantly higher NADH content in the msaABCR mutant than in the USA300 LAC
strain (Fig. 4.3D).
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Figure 4.3 Measurement of TCA cycle activity, intracellular ATP and NAD+/NADH
content
(A) Fold change expression of TCA genes (gltA, acnA, icd, sucA, sucD, sdhA/B, and fumC) in late
exponential growth phase for the msaABCR mutant compared with the USA300 LAC strain, as measured
by qRT-PCR. (B) The ATP concentrations per CFU of all strains were measured in late exponential and
(C) stationary growth phases. The data represent the average of three ATP concentrations per CFU for each
individual sample measured with two biological replicates. (D) Absolute concentration of NAD+/NADH
content in all strains grown to late exponential-phase. Error bars represent the SEM of the three
independent experiments. Statistical significance was determined using analysis of variance (ANOVA)
followed by Tukey’s multiple comparison test. *, P < 0.05; **, P < 0.001; ns, not significant.

44

4.4 Decreased Number of Persister Cells Form in the msaABCR Mutant During
Late Exponential-Phase
Since we observed increased TCA cycle activity and intracellular ATP level in the
msaABCR mutant, we hypothesized that this increased energy level would lead to
decreased persister formation. To test this prediction, we first measured the persister
fraction in late exponential growth phase in the presence of antibiotics targeting protein
synthesis (gentamicin), cell wall synthesis (vancomycin), and replication (ciprofloxacin).
Similar as of stationary-phase, in this phase of growth too, the msaABCR mutant was
eradicated by gentamicin after 24 h, whereas a fraction of USA300 LAC and
complementation strains showed prolonged survival for up to 48 h, with corresponding
biphasic killing curves (Fig. 4.4A, B).
Likewise, the msaABCR mutant showed significantly fewer persister cells than
the USA300 LAC and complementation strains when treated with vancomycin and
ciprofloxacin (Fig. 4.4C–F). Interestingly, all the test strains showed a higher fraction of
persister cells in the presence of ciprofloxacin than with gentamicin or vancomycin.
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Figure 4.4 The msaABCR mutant exhibits less antibiotic tolerance in the late
exponential-phase
(A, C, and E) The killing of USA300 LAC, isogenic msaABCR mutant, and complementation cells in the
presence of antibiotics at the indicated times. All strains were grown in TSB to late exponential growth
phase (OD600 nm of 4.0) and exposed to gentamycin (20 × MIC), vancomycin (100 × MIC), or
ciprofloxacin (100 × MIC). (B, D, and F) Bar graph showing the percentage survival of all strains measured
at the endpoint of each treatment. (A and B) Gentamycin treatment. (C and D) Vancomycin treatment. (E
and F) Ciprofloxacin treatment. Error bars represent the standard SEM from three independent
experiments. Statistical significance was determined using ANOVA followed by Tukey’s multiple
comparison tests. **, P < 0.001; ****, P < 0.0001.
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4.4.1 Increased Antibiotic Tolerance Corresponds with the Decreased Energy Level
in S. aureus Cells
The killing efficiency of all the bactericidal antibiotics depends on the cellular
energy level. Therefore, target inactivation due to a low-energy state should cause
increased tolerance to antibiotics in stationary-phase bacterial cells (24, 58). This
proposal has been supported by several studies that reported increased persister formation
corresponding to the depletion of ATP in different bacterial species (65, 66). These
studies, as well as our observations in late exponential-phase, suggest a causal link
between high intracellular ATP content and decreased persister formation in S. aureus
cells.
To further examine the importance of ATP in antibiotic tolerance, we measured
the persister fraction by depleting intracellular ATP with arsenate. Arsenate is a toxic
compound that uncouples oxidative phosphorylation subsequently producing a futile
respiration cycle (114). Arsenate resembles phosphate such that it can bind to ADP.
Therefore, the mechanism of the uncoupling involves the substitution of phosphate by
arsenate resulting in the synthesis of ADP-arsenate, which undergoes non-enzymic
hydrolyzed (115). Therefore, arsenate lowers the rate of ATP synthesis by forming
rapidly hydrolysable ADPs. When cell cultures were pre-exposed to 1 mM arsenate, the
intracellular ATP level was reduced, resulting in a dramatic increase in the persister level
in the msaABCR mutant that was comparable with the USA300 LAC and
complementation strains (Fig. 4.4.1A, B).
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These results together demonstrate that a high cellular energy level is necessary
for the killing efficiency of bactericidal antibiotics and that a low energy level increases
antibiotic tolerance in bacterial cells.

Figure 4.4.1 Association between cellular ATP and persister frequency
(A) ATP concentrations were measured at stationary growth phase in the presence and absence of 1 mM
arsenate. The data represent the average of three ATP concentrations per CFU of each individual sample
measured with two biological replicates. (B) Persister frequency (log10 survival fraction) was measured in
stationary-phase culture against gentamicin (20 × MIC), with and without prior exposure to arsenate (ars.).
The data represent the results from three independent experiments. Error bars represent the SEM. Statistical
significance was determined using ANOVA followed by Tukey’s multiple comparison tests. **, P < 0.001;
ns, not significant.

4.5 The msaABCR Operon Indirectly Regulates the TCA Cycle Activity
Since, we observed increased expression of TCA genes and ATP level in the
msaABCR mutant; next, we sought to examine msaABCR regulation of the TCA cycle.
The LysR-type regulator catabolite control protein (CcpE) functions as a major positive
transcriptional regulator of aconitase, encoded by the first gene in the TCA cycle (acnA)
(116). To delineate the regulatory role of the msaABCR operon, we measured the
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expression of ccpE in late exponential growth phase. The qRT-PCR revealed
upregulation of ccpE (>2-fold) in the msaABCR mutant compared with the USA300 LAC
strain (Fig. 4.5A). Likewise, in the late stages of S. aureus growth, catabolism of the
amino acid glutamate by glutamate dehydrogenase (gudB) ultimately fuels the TCA cycle
through 2-oxoglutarate. Further, to observe the specific requirement of amino acid
catabolism, we measured the expression of gudB in our test strains grown in chemically
defined media (CDM) containing amino acids. The qRT-PCR result showed increased
expression (>3-fold) of gudB in the msaABCR mutant compared with USA300 LAC
strain (Fig. 4.5A).
Further, to examine MsaB regulation of ccpE and gudB, we performed an
electrophoretic mobility shift assay (EMSA), which showed MsaB binding to the ccpE
promoter (Fig. 4.5B) and thereby suggested that MsaB regulates the TCA cycle via ccpE.
This also confirms our previous finding of MsaB regulation of ccpE in the UAMS-1
strain (99).
However, the absence of binding to the promoter of gudB (Fig. 4.5C), suggests
that its regulation by MsaB is indirect. All these observations lead us to conclude that
MsaB directly regulates ccpE to control TCA cycle activity and that the increased energy
state in the msaABCR mutant led to decreased persister cell formation in late exponential
growth phase.
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Figure 4.5 Measurement of expression and MsaB binding to the ccpE and gudB
(A) Fold change expression of ccpE in late exponential growth phase and gudB in the chemically defined
medium (CDM) for the msaABCR mutant compared with the USA300 LAC strain, as measured by qRTPCR. (B) MsaB binds to the ccpE promoter. Increasing concentrations of MsaB–His protein were
incubated with a biotin-labeled, 50-bp, dsDNA probe incorporating the promoter region of ccpE. The band
shift is shown in lane 5, while the shift was reversed in a competition assay with a 100-fold greater
concentration of unlabeled probe in lane 6. (C) MsaB does not bind to the promoter of gudB as evidenced
by the absence of band shift.

4.6 The msaABCR Operon Negatively Regulates the NADH Dehydrogenase (ndh2)
and Controls the Expression of ETC Genes
The activated TCA cycle generates large amounts of reduced dinucleotides, the
oxidation of which requires the electron transport chain (ETC) (94, 112). The electrons
entering into the ETC from NADH are transferred to menaquinone by the NADH
dehydrogenase complex. A series of oxidation reactions in cytochrome oxidases finally
produces water, while pumping of protons (H+) across the membrane produces pH and
electrochemical gradients or membrane potential (Δψ). In S. aureus, the NADH
dehydrogenase II (SAUSA300_0844, encoded by ndh2) and cytochrome aa3 oxidase
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(qoxBCD) contribute to the generation of membrane potential (117-119). Likewise, the
F1F0 ATPase (atpA) also contributes to the generation of PMF by pumping out protons
upon ATP hydrolysis (71, 120). In the stationary growth phase, the TCA cycle is derepressed when amino acids are catabolized. Therefore, we measured the relative
expression of genes involved in the ETC, including ndh2, qoxBCD, and atpA, in the test
strains grown in CDM containing amino acids. The qRT-PCR results showed a
significant increase (>2-fold) in expression of the ndh2, qoxBCD, and atpA genes in the
msaABCR mutant compared with the USA300 LAC strain (Fig. 4.6A).
A previous study reported that ndh2 is a major NADH: quinone oxidoreductase,
disruption of which showed a large reduction (70%) in membrane potential compared
with the wild type USA300 strain (118). Considering the importance of ndh2 in the
generation of membrane potential, we sought to investigate its regulation by MsaB. We
performed EMSA to examine the binding of MsaB to the promoter region of ndh2. The
result showed MsaB binding to ssDNA upstream of the transcription initiation site for
ndh2 (Fig. 4.6B). However, MsaB did not show binding to the same region when using
dsDNA. This result suggests that MsaB regulates ndh2, either at the post-transcriptional
level or as an RNA chaperone, as previously reported (105). Together, these observations
suggest that msaABCR (MsaB) directly regulates NADH oxidation via negative
regulation of ndh2 in the USA300 LAC strain.
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Figure 4.6 Expression of genes of electron transport chain (ETC) and MsaB binding to
ndh2
(A) Expression of ETC genes (ndh2, qoxB, qoxC, qoxD and atpA) was measured by qRT-PCR of RNA
samples isolated from cells grown overnight in chemically defined medium (CDM). The bar graph shows
the fold change in expression of genes in the msaABCR mutant compared with the isogenic USA300 LAC
strain. (B) EMSA showing MsaB binding to the promoter of ndh2. Increasing concentrations of MsaB were
incubated with appropriate concentrations of ssDNA from the region upstream of the transcription initiation
site for ndh2. The band shift was reduced in a competition assay with a 100-fold greater concentration of
unlabeled ndh2 probe.

4.7 The Membrane Potential Determines the Persister Formation in the StationaryPhase S. aureus Cells Against Aminoglycoside Stress
Since we observed upregulation of ETC genes in the msaABCR mutant, we
measured the membrane potential of our strains via flow cytometry using the fluorescent
membrane stain DiOC2 (3). The results showed higher membrane potential in the
msaABCR mutant than in the USA300 LAC strain (Fig. 4.7.1A). To further confirm the
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contribution of membrane potential in persister generation, we measured the persister
fraction in the presence of the proton iono-phore CCCP, a known inhibitor of PMF
generation that dissipates H+ ion gradients. As expected, in the presence of CCCP (> 0.1
M), the persister fraction in the msaABCR mutant reverted to a level comparable to the
USA300 LAC and complementation strains (Fig. 4.7.1B).
Likewise, CCCP (10 M) treatment drastically reduced the membrane potential in
both USA300 LAC and msaABCR mutant strains (Fig.4.7.1A). The requirement of
membrane potential in persister killing is further supported by the results from the
individual ndh2 and qoxB mutants. The ndh2 and qoxB mutants showed significantly
reduced membrane potential accompanied by an increased persister fraction relative to
the isogenic USA300 LAC strain (Fig. 4.7.1C, D). The atpA mutant also showed reduced
membraned potential relative to USA300 LAC but was not statistically significant (Fig.
4.7.1C). Additionally, atpA mutant did show increased persister fraction (Fig. 4.7.1D)
and reduced growth rate relative to the USA300 LAC strains.
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Figure 4.7.1 Decreased membrane potential causes increased persister cells formation
(A) Stationary-phase cells washed twice with PBS were incubated with 3, 3′-diethyloxacarbocyanine
iodide (DiOC2(3)) for 30 min in room temperature. After incubation, the cells were subjected to flow
cytometry. The data represents the ratio between channel F3 (red fluorescence) and F1 (green
fluorescence), calculated with FlowJo software. (B) Stationary-phase cells pre-incubated for 30 min
with different concentrations of CCCP were exposed to gentamicin (20 μg/ml). At 24 h post exposure,
the cells were harvested, washed, and plated for CFU counting. (C) Measurement of membrane potential.
(D) Persister fraction in the mutants of the ETC genes ndh2, qoxB, and atpA compared with the isogenic
USA300 LAC strain in the presence of gentamicin (20 μg/ml). Data represents the log10 survival fraction
for the average of three independent experiments. Error bars represent SEM. Statistical significance was
determined using student’s unpaired t-test. *, P < 0.05; **, P < 0.001; ns, not significant.

As we stated above, the stationary-phase msaABCR mutant did not exhibit a lowpersister phenotype in response to vancomycin or ciprofloxacin. Therefore, our
observations did not sufficiently justify the requirement of ATP for antibiotic tolerance in
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general, at least in the stationary growth phase. Indeed, a previous study demonstrated
that ATP does not determine a persister switch in stationary-phase S. aureus cells (71).
To further investigate this question, we measured ATP concentration in the
stationary-phase ndh2 mutant, which showed a similar level of ATP as the isogenic
USA300 LAC strain (Fig. 4.7.2), providing further evidence that ATP does not play a
deterministic role in persister generation during stationary growth, especially in the
presence of aminoglycoside.

Figure 4.7.2 Cellular ATP level in ndh2 mutant is comparable to that of USA300 LAC
The ATP concentrations per CFU were measured in the stationary growth phase. The data represent the
average of three ATP concentrations per CFU for each individual sample measured with two biological
replicates. Error bars represent the SEM for three independent experiments. ns, statistically not significant.

Taken together, these observations indicate that membrane potential is required
for the aminoglycoside killing of persister cells in the stationary growth phase and that
the msaABCR operon negatively regulates the generation of membrane potential, thereby
contributing to S. aureus tolerance towards aminoglycosides.
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4.8 Gentamicin Uptake is Higher in the msaABCR Mutant
It is known that PMF is necessary for aminoglycoside uptake in bacterial cells,
although the complete mechanism underlying this association is not clear (40, 121).
Aminoglycoside uptake, in turn, is increased with enhanced membrane potential.
Increased membrane potential as well as increased aminoglycoside killing of the
msaABCR mutant then led us to examine gentamicin uptake in our test strains using the
gentamicin :: Texas Red conjugate (Gen :: TR) method. Stationary-phase cells were
incubated with Gen :: TR, and its uptake was measured by flow cytometry. The results
showed higher gentamicin uptake in the msaABCR mutant than in the USA300 LAC
strain (Figure 4.8).

Figure 4.8 Measurement of gentamycin uptake
The conjugation of gentamycin with Texas-Red fluorescent (Gen :: TR) in 30:1 molar ratio was made in
anhydrous N, N-dimethylformamide. The mixture was gently rotated for 3 days at 4°C. The washed
stationary-phase cells were incubated with Gen :: TR for 3 h at 37°C with continuous shaking. After
incubation, cells were washed twice and re-suspended in 500 μl PBS and was measured in flow cytometry
with excitation/emission maxima at ~595/615 nm. The median values for PE-A were measured using
FlowJo software. The mean of median values for the three independent experiments were 3589 ± 538 for
USA300 LAC and 5356 ± 1021 for the msaABCR mutant.
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Together, these results suggest that deletion of msaABCR in S. aureus increases
the membrane potential, which causes higher aminoglycoside uptake, leading to creased
aminoglycoside tolerance.
4.9 The msaABCR Operon Regulates the Genes Involved in Oxidative Stress
Response
On transcriptomic analysis, we identified that the deletion of the msaABCR
operon in the USA300 LAC strain induced differential expression of more than 10 genes
that are involved in resisting oxidative stress (36). To further confirm, we measured the
expression of these genes by qRT-PCR (Table 4.9). In both the assays, among the
downregulated genes, notably, were the carotenoid biosynthetic genes crtM and crtN, ohr
(SAUSA300_0786), katA and membrane protein (SAUSA300_0374). In contrary, the
superoxide dismutases (sodA/M) were upregulated.
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Table 4.9 Fold change expression of oxidative stress responsive genes in the msaABCR
mutant relative to wild type strains
Fold Change in expression
Genes (Locus ID)

Functional name

USA300 LAC

UAMS-1
-3.25±0.05

crtM (SAUSA300_2499)

Squalene desaturase

-3.58±0.24

crtN SAUSA300_2498)

Squalene synthase

-2.99±0.74

ohr (SAUSA300_0786)

OsmC/Ohr family protein
gene

-3.8 ± 0.58

-2.18±0.11

katA(SAUSA300_1232)

Catalase

-2.38±0.48

-3.7±0.10

sodA(SAUSA300_0135)
Membrane protein
(SAUSA300_0374)

Superoxide dismutase

+2.98±0.25

+3.44±0.74

-3.2±0.15

-7.4±1.83

ahpC(SAUSA300_0380)

Putative membrane protein
Alkylhydroperoxide
reductase

-1.01±0.28

-4.49±0.83

trx (SAUSA300_0747)

Thioredoxin

-1.05±0.19

+1.8±0.70

dps (SAUSA300_2092)
glutathione peroxidase
(SAUSA300_1197)

General stress protein 20U

-1.26±0.12

-1.28±0.14

Glutathione peroxidase

+1.28±0.41

-2.65±0.44

uvrA (SAUSA300_0742)

Excinuclease ABC subunit A

-1.02±0.78

+2.43±0.37

-2.25±0.15

Values are represented as mean fold change ± standard error of the mean

4.10 The msaABCR Mutant is More Susceptible to Oxidative Stress In Vitro
The differential expression of oxidative stress resistance genes in the msaABCR
mutant suggested a possible regulatory role of the msaABCR operon in S. aureus
response against the oxidative stress. To study this, in vitro survival assays in the
presence of inorganic H2O2, organic hydroperoxides such as tert-butyl hydroperoxide
(tBOOH) and cumene hydroperoxide (CHP) were performed. Post exponentially grown
cells of wild type USA300 LAC and UAMS-1 strains, an isogenic msaABCR deletion
mutant, and their complementation cells were exposed to H2O2 for 1 h at 37°C. The
survival percentage measured after the incubation showed increased susceptibility of
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msaABCR mutant cells (1-log-fold reduction compared to that of the wild type), with
10% to 12% survival in wild type and 8% to 10% in complementation strains, while
survival was ~ 0.5% for msaABCR mutant cells in both strain backgrounds (Fig. 4.10.1).

Figure 4.10.1 Oxidative stress survival assays in the presence of H2O2
S. aureus cells grown for 24 h were washed and normalized to OD600 nm of 0.1 in 1 ml phosphate buffer
saline (PBS) containing 34 mM H2O2 and were incubated for 1 h at 37°C. After incubation, catalase (2000
U/ml) was added and the mixture was incubated for 1 min at room temperature to decompose H2O2. Cells
were diluted and plated for CFUs count. The survival percentage represents the percentage of initial CFUs
that survived the H2O2 exposure in1 h. The data represent the SEM of the results of at least three
independent experiments. Student’s unpaired t-test was used to compare the results of wild types to the
isogenic mutants. ***, P < 0.001. aFSmut-msaB, msaABCR complemented with frameshift mutated msaB.

To examine the tolerance towards oxidative stress, we also tested the growth
pattern of the msaABCR mutant in the presence of 25 mM H2O2 in the nutrient-rich TSB
medium. We observed that the growth of USA300 LAC and complementation cells was
halted for 5 h. After this tolerant phase, the wild type and complementation cells resumed
growth to similar levels as those under unstressed conditions. However, growth of the
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msaABCR mutant was reduced gradually to below the limit of detection (100 CFU/ml),
resulting in a clear culture (Fig. 4.10.2A, C).
On the other hand, the growth of UAMS-1 and msaABCR mutant cells was
reduced in the presence of 25 mM H2O2 compared to that of the unstressed cells after an
overnight incubation, while such growth delay was not observed in complementation
cells (Fig. 4.10.2B, D). To confirm whether the killing was by ROS production, we added
50 mM thiourea, an ROS scavenger, to the msaABCR mutant cells after 10 min of H2O2
treatment. In the presence of thiourea, they resumed growth similar to that under the
H2O2-unstressed condition (Fig. 4.10.2E). These observations suggest that the msaABCR
mutant is more susceptible to ROS generated from H2O2.
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Figure 4.10.2 Growth of msaABCR mutant is severely disrupted in the presence of H2O2
S. aureus cells grown for 24 h were normalized to an OD 600 nm of 0.1 in 5 ml TSB with 25 mM H2O2. (A
and B) Growth was monitored by CFUs count at different time points as indicated. (C and D) Observation
of culture growth with and without 25 mM H2O2 incubated overnight. (E) Addition of 50 mM thiourea to
the H2O2-stressed cells. The data present the mean±SEM of the results, which were repeated at least three
times.
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4.11 The Resistance Towards H2O2 is Mediated Through Staphyloxanthin (STX)
Production by the msaABCR
The carotenoid pigment is the membrane-bound orange red C30 triterpenoid STX,
the biosynthesis of which is encoded by the genes within the operon containing
crtOPQMN and aldH (37, 38). Previously, we showed that deletion of the msaABCR
operon significantly reduced pigmentation in S. aureus (97). On trans-complementation
of the msaABCR mutant with the native msaABCR operon, the STX level was completely
restored. However, trans-complementation with the FSmut-msaB msaABCR operon did
not restore STX production in the msaABCR mutant. In fact, the FSmut-msaB msaABCR
operon showed a similar level of STX defect as the msaABCR operon mutant (Fig.
4.11A, B). Furthermore, the trans-complemented FSmut-msaB msaABCR operon cells
also showed similar susceptibility to H2O2 killing as msaABCR cells. Taken together,
these observations indicate that the msaB gene and/or protein is responsible for the STX
production that corresponds to H2O2 susceptibility in S. aureus.
In addition to significant downregulation of the crtM and crtN genes, our
proteomics results also revealed a decreased level of carotenoid protein in the USA300
LAC msaABCR mutant. To further verify the importance of STX in ROS resistance in
our strain background, the crtM mutant, which is devoid of pigment production, was
exposed to H2O2 stress that showed increased susceptibility, comparable with that of
msaABCR mutant cells (data not shown). All these findings indicate the importance of
functional MsaB in resisting H2O2 killing, which is likely to be mediated through STX
production.
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Figure 4.11 Measurement of STX
(A) Standardized S. aureus cells in 10 ml TSB were grown for 36 h at 37° C with continuous shaking. Cells
were harvested, washed with deionized water, and normalized to an OD 600 of 10 in 1 ml. Then, STX was
extracted using the methanol extraction method. The values are presented relative to the wild type
normalized to 1. (B) The corresponding pictorial representation of pigmentation. The data represent the
SEM of the results of four independent experiments. Student’s unpaired t-test was used to compare the
results for wild type with that of the mutants. *, P < 0.05.

4.12 MsaB is a Positive Transcriptional Regulator of the crtOPQMN Operon, which
is Epistatic to Alternative Sigma Factor B (SigB)
To investigate whether the MsaB regulation of the crtOPQMN operon is direct,
we performed a ChIP assay using an MsaB antibody at the stationary growth phase, in
which STX production is visible. The wild type and msaABCR mutant cells were grown
to stationary growth phase, and crosslinking of MsaB to its target DNA promoters was
facilitated by treating the cells with a final concentration of 10 mM sodium phosphate
and 1% formaldehyde. The MsaB–DNA complexes were then pulled down using an
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MsaB antibody. To confirm specificity, the msaABCR mutant cells were included as a
negative control in each assay. In our previous study we demonstrated the existence of a
consensus sequence including the TTGTTTAAA region upstream of the cap promoter for
MsaB binding (102). The primers specific for the crtOPQMN operon promoter region
comprising the consensus repeat target sequence of MsaB were designed and used to test
the amplification. The binding activity of MsaB revealed via ChIP assay indeed confirms
that MsaB is a direct regulator of the crtOPQMN operon (Fig. 4.12A).

Figure 4.12 Chromatin immunoprecipitation (ChIP) assay
ChIP using an anti-MsaB antibody was performed to determine MsaB binding to the promoter region of
(A) crtOPQMN operon, (B) ohr gene, and (C) sarZ gene. Primers specific for the corresponding promoter
regions were used to amplify DNA after immunoprecipitation of wild type USA300 LAC cells. msaABCR,
the negative control, which is a whole-cell extract from the msaABCR deletion mutant with anti-MsaB
antibody. + control, PCR amplification from genomic DNA of the wild type strain, LAC::Tn SigB,
immunoprecipitated DNA isolated from a transposon mutant of sigB in the USA300 LAC strain. P, the
promoter region of corresponding gene.
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Previous studies have shown sigB to be a positive transcriptional regulator of the
crtMN operon (122, 123). Deletion of msaABCR downregulates the transcription of sigB
by 3.2 and 2.31-fold in the USA300 LAC and UAMS-1 strain backgrounds, respectively
(Table 4.12). To examine whether SigB affects the binding of MsaB to the crtOPQMN
operon promoter, we employed a Chromatin Immunoprecipitation (ChIP) assay with a
sigB transposon mutant of the USA300 LAC strain. Our result showed that MsaB does
also bind to the crtOPQMN promoter in the absence of sigB (Fig. 4.12A).
Table 4.12 Fold change in the expression of stress responsive regulators in the msaABCR
mutant relative to wild type strains
Fold change in expression
Genes (Locus ID)

USA300 LAC

UAMS-1

sigB (SAUSA300_2025)

–3.29±0.12

–2.31±0.14

ssrA (SAUSA300_ 0766)
sarZ (SAUSA300_2331)

+2.21±0.08
+2.65±0.05

+10.83±0.19
+3.39±0.18

Values are represented as mean fold change ± SEM of three independent experiments.

However, in the absence of MsaB binding to the crtOPQMN operon alone was
not sufficient to activate crtM/N expression and/or pigmentation. These results led us to
conclude that both MsaB and SigB are required for crtOPQMN operon expression and/or
pigmentation and that their regulation is mutually epistatic. We were then interested to
see how msaB transcription was affected by sigB. The sigB mutation resulted in
upregulated msaB transcription by 9-fold, indicating that sigB is a repressor of msaB
expression. These results indicate the interaction between MsaB and SigB and the
mechanism of regulation of the crtOPQMN operon are indeed complex and need further
investigation for complete understanding.
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4.13 MsaB Positively Regulates ohr to Resist the Oxidative Stress Generated in the
Presence of Organic Hydroperoxides
The ohr gene encodes a protein that confers resistance to organic hydroperoxide
in different bacterial species, including E. coli, P. aeruginosa, X. campestris, and S.
aureus (124-128). Deletion of the msaABCR operon resulted in the repression of ohr
transcripts. This result led us to speculate whether the mutant is more susceptible to the
organic hydroperoxides. In the presence of organic hydroperoxides tBOOH and CHP, we
observed a significantly decreased survival percentage of msaABCR mutant cells
compared with those of wild type and complementation cells in both USA300 LAC and
UAMS-1 strains (Fig. 4.13). We observed that ohr mutant cells have increased
susceptibility to tBOOH- and CHP-induced oxidative stress that is comparable to
msaABCR mutant cells (Fig. 4.13).
To examine whether the altered sensitivity to organic peroxides in
msaABCR mutant cells is due to repression of ohr, a plasmid for inducible expression
of the ohr gene (msaABCR :: POhr) was constructed and then transformed into msaABCR
mutant cells. Overexpression of the ohr gene in the msaABCR mutant cells increased
resistance against tBOOH and CHP to a level comparable to wild type. These results
suggest that response of MsaB to organic hydroperoxide stress is likely to be dependent
on the ohr gene in S. aureus (Fig. 4.13).
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Figure 4.13 Survival assay in the presence of organic hydroperoxides
S. aureus cells grown for 16 h were harvested, washed and normalized in PBS to OD600 6.0 of all strains
tested. Then, 10 μl of serially diluted cells (10-1 to 10-8) were dropped onto the TSA plates containing 5
mM tBOOH (A and B) and 4 mM CHP (C). Plates were incubated 24 h for CFUs count. Graphs represent
the percentage of survived CFUs. Error bars represent SEM of the results repeated three times. Student’s
unpaired t-test was used to compare the results of wild types to the isogenic mutants. *, P < 0.05; **, P <
0.005.
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Besides, the positive binding results in these assays confirmed that MsaB directly
regulates the ohr gene (Fig.4.12B). A previous study by Chen et al. (91) showed that
SarZ is a multigene regulator (Mgr) homologue that negatively regulates the ohr gene in
S. aureus strain Newman (91). Under stationary growth conditions, we observed that
sarZ expression was upregulated by 2.65, and 3.39-fold in the msaABCR mutants of the
USA300 LAC and UAMS-1 strains, respectively (Table 4.12).
We then sought to determine whether MsaB also regulates sarZ expression. The
positive binding activity observed in the ChIP assay indeed demonstrates that MsaB also
regulates sarZ (Fig. 4.12C). The findings from this study thus led us to conclude that
MsaB directly regulates the ohr as a transcriptional activator and sarZ as a transcriptional
repressor.
4.14 The msaABCR Operon is Crucial to Persist Inside the Host Immune Cells
Since the deletion of the msaABCR led to the differential expression of oxidative
stress responsive genes as well as reduced survival in the presence of H2O2 and organic
hydroxides, we sought to examine whether these phenotypes are translated into decreased
bacterial resistance against innate immune clearance in ex vivo systems including
macrophages, neutrophils, and whole-blood cells that additionally contain
complementing proteins. Post exponentially grown cultures of bacterial cells were
incubated with macrophages (RAW 264.7 cells), freshly collected neutrophils, and
heparinized whole-blood cells from volunteers. We observed that msaABCR mutant cells
were significantly defective in intracellular survival within macrophages, human
neutrophils, and whole-blood cells. Complementation of the mutants with a functional
68

copy of the msaABCR operon restored their survival to a level comparable with that of
the wild type in neutrophils and human blood and to lesser extent (~70% survival
compared to wild type) in macrophages (Fig. 4.14). These results indicate that msaABCR
is crucial for S. aureus survival intracellularly of the host immune systems, which
produce ROS that are lethal to the pathogens.

Figure 4.14 Ex vivo survival assay with macrophages, neutrophils and human wholeblood cells
(A) S. aureus cells with a multiplicity of infection (MOI) of 10 were incubated with macrophages
(RAW264.7 cells) at 37℃ in the presence of CO2. (B) S. aureus cells were incubated with heparinized
human whole blood and freshly isolated human neutrophils to measure their intracellular survival rates.
Results with human blood and neutrophils for the UAMS-1 strain were reported in a previous study (102).
The data represent the means of three independent experiments. Error bars represent the standard error
(SE). Student’s unpaired t-test was used to compare the results from wild types and their isogenic
msaABCR mutants. **, P < 0.005.
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CHAPTER V – DISCUSSION
This study identifies the novel role of the msaABCR operon in antibiotic
persistence as well as in stress response. Specifically, in dissecting the mechanism, we
report (a) the regulatory role of msaABCR in persister cells development by modulating
energy metabolism in S. aureus. And, (b) we demonstrate the msaABCR regulation of
oxidative stress response in S. aureus.
5.1 Persister Frequency Depended on Growth Phase and Antibiotics Used
In persister assays, we observed different trajectories of killing curves and
persister plateau dependent on growth phases and the antibiotics used. This is
conceivable since the robustness of the persister population depend on the kind of
antibiotic stress that lead to the generation of physiologically heterogeneous population
in bacterial cells (40, 129). Exponentially grown msaABCR mutant formed significantly
less persister cells in most of the antibiotic used, whereas, the biofilms of msaABCR
showed pronounced defect in persister cells formation against all antibiotic stresses.
Previously, we showed that the immature biofilm in the msaABCR mutant is mediated
through the increased processing of major autolysin Atl, by excessive protease production
which led to uncontrolled cell death (98). However, the contribution of protease
production to decreased antibiotic tolerance remains to be elucidated. Nonetheless, we
reasoned that the loosely connected weak biofilms of the msaABCR mutant would not be
as favorable as the robust biofilms of wild type USA300 LAC for generation of
extremely tolerant persister cells. Likewise, in the stationary state of growth, the
msaABCR mutant failed to form persister cells under aminoglycoside stress, showing
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little to no effect in other antibiotics used, suggesting antibiotic dependent specific
mechanism of the msaABCR regulation of tolerance in S. aureus.
In a growing population, the frequency of persister cells depends on reduced
expression of TCA enzymes accompanied by low ATP levels (65, 72). Although the
msaABCR mutant exhibited higher ATP levels, the persister fraction in late exponentialphase varied among the antibiotic classes. For instance, gentamicin eradicated msaABCR
mutant cells within 48 h. By contrast, a high persister fraction (~10%) was observed in
the presence of ciprofloxacin for more than 4 days, whereas a persister fraction was
observed to a lesser extent (~0.001%) in the presence of vancomycin. While it is not a
unique observation that the efficiency of bactericidal antibiotics depends on the energy
state of cells, the persister phenomenon seems to depend on how the bacterium responds
to a stress in general. In support of this speculation, a recent study has indeed
demonstrated the formation of intracellular persister cells in response to an antibiotic
stress that also displayed multiple stress responses in S. aureus (64).
5.2 Cellular ATP Level is not the Deterministic Factor for Decreased Persister
As we observed a drastic increase in antibiotic tolerance and reduced intracellular
ATP levels, our findings confirmed that cellular energy is required for the killing
efficiency of bactericidal antibiotics. However, besides ATP, other factors seem to
contribute to antibiotic tolerance. These factors may vary, depending largely on the
growth phase, which in turn determines whether persister cells are generated or
maintained and whether the cells are active or not. For instance, due to slow growth,
stationary-phase cells exhibit extreme tolerance to most antibiotics, including
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vancomycin, which kill actively growing cells. Since the msaABCR mutant has similar
growth and yield as that of the USA300 LAC strain, the killing efficiency of vancomycin
and ciprofloxacin does not appear to be influenced by ATP concentration, especially in
the stationary-phase. By contrast, we reasoned that the increased energy state along with
the presence of active targets contributes to increased killing of the msaABCR mutant by
bactericidal antibiotics during late exponential growth phase. It is also possible that
deletion of msaABCR reduces the stochastic events of reduced TCA enzyme expression
during exponential growth phase, resulting in a decreased persister fraction. On the other
hand, the fact that stationary-phase msaABCR mutant cells are eradicated only by
aminoglycosides suggests a different mechanism of persister killing.
5.3 Membrane Potential Associates with Persister Fraction Against Aminoglycoside
Stress
Studies have shown a causal link between persister formation and membrane
potential, primarily in the presence of aminoglycosides. A decreased persister fraction
was observed in response to enhanced membrane potential and subsequently increased
aminoglycoside uptake (40, 130, 131). Likewise, reduced membrane potential was shown
to cause an increased persister fraction in the TCA mutants of S. aureus (71). The SCVs
of S. aureus were also found to display increased resistance towards aminoglycosides due
to low membrane potential (132). Likewise, disruption of serine biosynthesis (serA) with
subsequently increased PMF led to a decreased persister frequency in E. coli (131). A
recent study showed increased antibiotic tolerance associated with reduced ATP and
membrane potential in S. aureus cells in a polymicrobial culture (73). Despite a plethora
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of clues, the complete mechanism linking persister formation and membrane potential is
not understood.
According to our observations, it appears that the contributions of the energy state
and membrane potential in antibiotic tolerance depend largely on the nature of the
antibiotic stress. Nonetheless, we conclude that deletion of msaABCR induces S. aureus
cells to transition to a higher energy state, causing decreased persister cell formation
during exponential growth, irrespective of the antibiotics used. Whereas, due to higher
membrane potential, stationary-phase msaABCR mutant cells failed to form persister
cells, especially in response to aminoglycoside antibiotics.
5.4 The msaABCR Operon Could be a Therapeutic Target for Persistent Infections
Considering the urgent clinical relevance of persister cells, understanding the
possible mechanisms of their eradication is highly important in selecting a therapeutic
target. S. aureus systemic infections those are mainly associated with biofilms, which are
difficult to treat. So far, eradication of persisters by aminoglycosides has been achieved
in conjunction with the metabolites mannitol and fructose, by an ATP-independent
acyldepsipeptide antibiotic (ADEP4), by drugs in combination with reactive oxygen
species, and by membrane disruption-mediated clearance in different bacterial systems
(33, 39, 40, 133, 134). However, there has been a lack of clinical efficacy for these
strategies. On the other hand, the use of traditional antibiotics would be beneficial,
considering the requirement of exhaustive clinical trials for novel therapeutics.
Administration of gentamicin to treat S. aureus infections is widely used in
clinical settings, and evidence confirms successful treatment of S. aureus systemic and
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skin infections with gentamicin without any adverse side effects (135, 136). Similarly,
treatment with gentamicin was shown to control α-toxin production (137). Likewise,
gentamicin was found to shorten treatment duration when prescribed in combination with
daptomycin and vancomycin (138). All these results suggest that gentamicin is a potential
antibiotic against S. aureus infections. However, increased evidence of treatment failures
due to the presence of persister cells warrants identification of the factors influencing
their formation. Our observations further indicate that msaABCR is a potential target to
eradicate S. aureus persister cells, and it appears that the use of gentamicin in conjunction
with a compound that inhibits msaABCR could be a successful therapeutic approach to
treating recalcitrant S. aureus infections due to the presence of elusive persister cells.
5.5 The Resistance Towards Oxidative Stress is Regulated via the msaABCR
Modulation of STX Production
In S. aureus, oxidative stress acts as a trigger for the expression of a multitude of
responses (139, 140) that have evolved as complex regulatory systems in the pathogen to
combat deleterious effects of environmental stimuli (74, 141). The carotenoid pigment
STX is known to quench toxic singlet oxygen due to the presence of numerous
conjugated double bonds (142-144). Studies have shown that mutants deficient in
carotenoid production have increased susceptibility to in vitro oxidative stress, are more
readily cleared by host immune cells (82, 141, 145, 146), and consequently demonstrate
reduced virulence and survival in a murine model (145, 147, 148). Recently, a twocomponent system, AirSR, was shown to transcriptionally regulate the crtOPQMN
operon in the S. aureus strain WCUH29 (123). Katzif et al. (122)(39) demonstrated
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reduced crtM transcription in the msaB mutant. Although the putative DNA-binding sites
for MsaB were predicted upstream of the promoter of the crtMN transcript (122) studies
remained inconclusive whether MsaB mediates direct regulation of pigment production
(105, 122, 149, 150). However, transcription of the crtOPQMN operon is shown to be
positively regulated by the RsbUVW-SigmaB system (122, 150-152) and MsaB (122)
and negatively regulated by small stable RNA A (ssrA) (153). In this study, we found that
MsaB indeed directly binds the crtOPQMN operon confirming that it regulates the
crtOPQMN transcripts. However, importantly, in the sigB mutant, the binding of MsaB to
the crtOPQMN promoter was not regulatory, since the binding by MsaB does not appear
to increase STX production in the absence of sigB. These observations indicate that
transcriptional regulation of the crtOPQMN operon by the two regulators MsaB and SigB
is rather complex, which needs to be further defined. Moreover, a recent study by
Caballero et al. (105) showed MsaB binding to rsbVWsigB mRNA as a RNA chaperone,
indicating the role of MsaB in sigB regulation (105).
Consistent with the previous study, we observed a lower level of STX production
in the sigB mutant than in the msaABCR mutant (122). Interestingly, in agreement with a
previous report (150), the sigB mutant demonstrated no sensitivity toward H2O2
compared with that of the isogenic wild type strain. These observations indicate that
although SigB and MsaB are both required for STX production, the resistance to
oxidative stress that is mediated through pigmentation is dependent on msaABCR operon
regulation. Liu et al. (153) showed the involvement of ssrA RNA as a negative regulator
for STX production via base pairing with the ribosomal binding site of crtM mRNA in S.
75

aureus (153). In msaABCR deletion mutants, transcripts of ssrA are upregulated.
However, it is unclear whether or how this effect is linked to crtOPQMN regulation by
MsaB.
5.6 The msaABCR Operon Regulates the Resistance Towards Organic
Hydroperoxides via ohr
Inactivation of osmC and ohr genes results in increased susceptibility toward
intracellular killing by macrophages, which clear pathogens mainly by ROS-mediated
killing (76, 154). The inactivation of OsmC and Ohr proteins in bacterial species was
shown to be associated with increased susceptibility toward organic hydroperoxides, with
little to no effect on H2O2 susceptibility (128, 155-158). The expression of Ohr is
regulated by the organic hydroperoxide stress resistance regulator (OhrR) in different
bacterial species (126, 127) In S. aureus, MgrA and SarZ have been considered paralogs
of OhrR, functioning as a transcriptional regulator of Ohr (91, 140), which is mainly
involved in sensing and resisting organic peroxide stresses. Chen et al. (91) identified
SarZ as a functional homologue of MgrA, which acts as a global regulator for the
expression of ~87 genes in S. aureus. In addition, the authors found SarZ to be a
repressor of ohr, which was shown to be involved in resisting peroxide stress in S. aureus
(91). SarZ represses not only ohr transcription but also msaABCR. Conversely, msaABCR
activates both ohr and sarZ transcription. Recently, MsaB was shown to bind sarZ and
mgrA mRNA as an RNA chaperon (105), suggesting their regulation by MsaB. All these
results indicate the complex regulatory interplay among these regulators in sensing and
responding to the oxidative stress.
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Consistent with previous studies (128, 155-158), we found that inactivation of ohr
resulted in hyper-susceptibility toward both organic hydroperoxides tBOOH and CHP,
with little to no sensitivity toward H2O2 (data not shown). Furthermore, overexpression of
the ohr gene in the msaABCR mutant increased resistance against tBOOH and CHP,
suggesting that MsaB responds to organic hydroperoxide stress that is likely to depend on
the ohr gene. However, we need further investigation into how MsaB senses peroxide
stress and coordinates the expression of genes in response to oxidative stress stimuli.
5.7 The msaABCR Operon is Crucial for Adaptation During S. aureus Infection
We observed downregulation of katA and ahpC transcripts in msaABCR mutants
in both the USA300 LAC and UAMS-1 strains. Of note, the katA and ahpC genes are
required for survival, nasal colonization, and persistence of S. aureus via peroxide
resistance (84). Reduced transcription of katA and ahpC in the msaABCR mutant
indicates the possibility that the msaABCR mutant could also be less persistent under in
vivo conditions. This speculation is corroborated by our findings showing that msaABCR
mutants are highly susceptible to clearance by host immune cells.
S. aureus has been reported to be a major intracellular persisting pathogen in
chronic and recurrent infections (33, 159). Richards et al. (160) reported the existence of
S. aureus clinical isolates with unique immune evasion ability and increased levels of
stress-response proteins, including cold shock protein CspA, in persistent bacteremia
cases (160). In addition to this study, several other studies also reported increased levels
of MsaB (CspA) and oxidative stress-response proteins, including thioredoxin (Trx), in
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staphylococcal infections (160-162), highlighting their importance in stress response and
their role in causing persistent S. aureus infections in the host.
Oxidative stress triggers a multitude of responses in bacterial pathogens. While
these protective strategies are crucial for bacterial survival and persistence in response to
various environmental stimuli, the inability to cope with these stresses leads to the rapid
clearance of pathogens by host immune cells. Likewise, antibiotic-generated ROS have
been discovered to be crucial molecules that enhance the bactericidal activity of drugs
against antibiotic-tolerant persister cells (163), whereas tolerance to antibiotics has been
suggested as depending on the cell’s protective strategies against lethal ROS (164, 165).
All these observations show that the msaABCR operon is highly important to S. aureus,
contributing to its ability to survive in diverse environments, an ability that facilitates the
pathogen in causing persistent infections.
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CHAPTER VI - CONCLUSION AND FUTURE DIRECTIONS
6.1 Conclusion
All the observations reported in this study lead us to conclude that the deletion of
the msaABCR operon induces a metabolically hyperactive state in S. aureus cells, as
shown by higher TCA cycle activity and higher ATP content. This increased energy state
of the msaABCR mutant leads to decreased persister formation in the presence of
different classes of antibiotics in the late exponential growth phase. In stationary-phase,
however, deletion of the msaABCR operon causes increased membrane potential in S.
aureus cells, which makes a significant contribution to the abrogation of tolerance,
specifically towards aminoglycosides. Based on the observations reported in this study,
we propose a mechanistic model of msaABCR regulation of TCA cycle activity and
NADH oxidation in USA300 LAC cells (Fig. 6.1.1). The msaABCR operon (MsaB)
directly represses ccpE and indirectly represses gudB to regulate TCA cycle activity and
subsequent intracellular ATP levels in S. aureus cells. In addition, the msaABCR operon
(MsaB) directly represses ndh2, a major NADH: quinone oxidoreductase to regulate the
generation of membrane potential in S. aureus cells.
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Figure 6.1.1 An Overview of msaABCR (MsaB) regulation of the energy metabolism
Inactivation of msaABCR in S. aureus upregulates ccpE, which in turn positively regulates acnA
expression. The consequent increased activation of the TCA cycle results in increased ATP and NADH.
Oxidation of NADH, in turn, increases the membrane potential. MsaB also controls the expression of the
ETC gene ndh2 as an RNA chaperone. This process leads subsequently to the biosynthesis of ATP by the
F0F1 ATPase in S. aureus.

Additionally, this study highlights the importance of msaABCR in the survival of
S. aureus in the presence of various environmental stimuli that mainly exert oxidative
stress. The results from this study demonstrate the importance of the msaABCR operon in

80

a complex regulatory network against resisting oxidative stress by S. aureus. The
interplay between these regulators is depicted (Fig. 6.1.2).

Figure 6.1.2 Regulatory map of oxidative stress defense system
MsaB positively activates transcription of the STX biosynthetic operon crtOPQMN and ohr gene. In
addition, MsaB also activates the expression of sigB, which is a positive transcriptional regulator of
crtOPQMN expression, and the regulation of the two genes seems to be mutually epistatic. On the other
hand, MsaB represses sarZ, which in turn also represses the ohr gene. The oxidative sensing pathway by
MsaB and the expression of genes remains to be elucidated. At this time, although we do not know whether
SigB and SarZ directly regulate MsaB, the increased transcription of msaB in the sarZ and sigB mutants
indicates the possibility of interplay between these regulators and MsaB.

All these observations show that the msaABCR operon is highly important to S.
aureus, contributing to its ability to survive in diverse environments, an ability that
facilitates the pathogen in causing persistent infections. Given the possibility that the
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msaABCR operon induces the persistence of S. aureus infections, these results underscore
that the operon could be a potential antimicrobial target to overcome recalcitrant
staphylococcal infections.
6.2 Future Directions
Our observations of in vitro studies suggest that the msaABCR operon is crucial
for S. aureus adaptation in environmental stress during infection. However, msaABCRmodulation of expression of the genes for adaptive responses inside the host cells remains
to be understood. Understanding the regulation of intracellular persistence including that
inside the non-phagocytic cells (osteoblasts, endothelial cells) is essential to control the
recurrent S. aureus infections. Indeed, this is the area which is largely unknown in S.
aureus. Therefore, understanding how the msaABCR operon senses the environmental
cues, directs the gene expression and facilitates the persistence of S. aureus intracellularly
would be an interesting and remarkable finding to design therapeutics.
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Table 4.13 Lists of primers and probes used in this study
Primers (qRT-PCR)

Sequence (5’→ 3’ ends)

gyrA F

GCCGTCAGTCTTACCTGCTC

gyrA R

TTTGCATCCTTACGCACATC

gyrB F

GGTGCTGGGCAAATACAAGT

gyrB R

TCCCACACTAAATGGTGCAA

crtM F

AAGTATTTAGTATTGAAGCACAAC

crtM R

ACGTTCATGTAATGTATAGTTAGC

crtN F

TACTAGGATTTTTAGCGTCGAAAC

crtN R

AAGAAGTTTTTGATGAAGCGATAG

ohr F

CGTAAAGGACATGTTTATACTGATGA

ohr R

TGTAAATATTTTTCAGCTTCTTCTTG

katA F

TTTAGTAGGGAATAACACACCAGT

katA R

CTCATATTTGTTCTAGGATCTCGT

sodA F

ACTAGCGGATATGATTGCTAACTT

sodA R

ATTTCCCAGAATAATGAATGGTTA

sodM F

CTGTACCTTCTACTGCAGCATTTA

sodM R

TTAGAACCACATTTTGACAAAGAA

Membrane protein F

ATGTTTGGATTTATTGGAATGTTAAT

Membrane protein R

AAAATACCACCTGGGATATCTTTAC

ahpC F

TTAGGCGTAAATGTATTCTCAGTA

ahpC R

CACCAATCATAGTGTAAGTGATTT

trx F

CTATGAAGGTAAAGCTGACATTTT

trx R

TTTAAAGACGATTAATGTTGGAAT

dps F

AAAAGAATTGAATCAACAAGTAGC

dps R

AACGTGTAATGAGAAGAAGTTAGG

Glutathione peroxide F

CGTTATGCTAATTGTTAATACAGC

Glutathione peroxide R

ATTACAAACCCTTGATCTTTGTAT

uvrA F

ACACGTGAAATGATGAGTAAAT

uvrA R

CCACCTACATAAACAGATAACG

sarZ F

TTGTAGGTTTCTTTCATCTTTCTC

sarZ R

GTTCTTAGATTCTGGAACACTGAC
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Table 4.13 (continued)
sigB F

GAAGCTAAGTCTATCTCTTTATCGTGAA

sigB R

CAAGAAATCGTTAAAGGCTTTGGTTATA

ssrA F

ATCAAACAATAATTTCGCAGTA

ssrA R

GCATATCCTATTAAGGTTGAATC

gltA F

AAATCGTTATGAAAGAGCAATG

gltA R

GGATTAGGCTTAAGTGGTTCTT

acnA F

ATAGTGTTGTAACACCTGAATTAT

acnA R

CATATAGAGGTTGATCAGTTACAT

icd F

ATTGCTGACATTTTCTTACAAC

icd R

AGCATCTGAAATATAGTCACCA

sucA F

CAGATGACGTTGAAGCTACTAT

sucA R

CGACGATAACCTACTAAATCAA

sucD F

TTGACTGAAGAAGGTATTGGTC

sucD R

TTGACTGAAGAAGGTATTGGTC

sdhA F

TGAAATTATGACAGCAAATGTAAC

sdhA R

CAATATCTTCATAACGTTTCATCA

sdhB F

TTCTATGGTTATCAATGGTCGT

sdhB R

TAACTGGGAAAGTATTCATTGG

fumC F

TCGAAGTAGTTTATGGTTTTGC

fumC R

CGTATACAATGGCATCTTTCTT

ndh2 F

AAATATGGTGTGGATCAAAATA

ndh2 R

TAACTGCGTGGTTAACTAATTC

qoxB F

CTTAATAGCTATACAAATTTCAGG

qoxB R

ATAAACTTCATAGTTGGTGTTTTA

qoxC F

TACACATGTGGTATTGCTATTTACTA

qoxC R

CAAAGACTAAACCTAAAAGTAACGTA

qoxD F

GTTTACGTAACACTATACACGTCA

qoxD R

TGAACATTAATAATTGAAGTCCTG

atpA F

TAGAAAGAGCAGCAAAATTAAA

atpA R

TTGTTGGTACATAAGCTGAAAT
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Table 4.13 (continued)
gudB F

AAGCATTGCATAAATTGGGATT

gudB R

CCATCATCCATTCGTACAGG

For EMSA
Biotin-ssDNA-5’ndh2

GTCTTTTTTGTGAACATCACAGGTTTTTAC
ATAATTTAAAAGACTTAAATAACAAAATG
ATGATAAACTAGTATA

ccpE

Biotin-duplex-5’GTTAGTAATGAACTCATGAATGCTTGTGCC
ATAA
GTTCAATAATTGAATAATTTATGGGG

gudB

Biotin-duplex-5’GGAAATTCAATATGTTTGAAAGCGAATCA
TTAGGTAAAGAAGAGGCGAAAAGGATC

For frame-shift mutant msaB (FSmutmsaB)
Fsmut-msaB F1

ACTTGTAAATGGATCCGTCTCATTTTTACC
ACCTCA

Fsmut-msaB R1

TCCTTTTTCAGCGTTAAACCATTTAAACTG
TACCTTGTTTCAT

Fsmut-msaB F2

ATGAAACAAGGTACAGTTTAAATGGTTTA
ACGCTGAAAAAGGA

Fsmut-msaB R2

AGTTATAAAGCGTACATCGTTAAGACAAC
TCATTA

Primers for ChIP assay
crtOPQMN-ChIP-F

CTAATGGTTATGCATCAGGAAGTAAC

crtOPQMN-ChIP-R

CTAAATTGAATCACTCTCAATCATACTGAC

ohr- ChIP-F

GAATCCCTCATTTCAGATACTC

ohr-ChIP-R

GCCATACTTATAACCTCCTAATT

sarZ-ChIP-F

AACAATTAAGGATGATACAATTACA

sarZ-ChIP-R

CAATCACTCCTTGTTAAAATAAA
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Table 4.13 (continued)
For complement and over-expression construct
Ohr-Comp-F

AGTCTGGATCCGTTTCTTCGATAGATAA
TTGTGGC
ACGTTGAATTCTCTCTTTAAGTTAATGC
TAATCTA
ATGTATTTTAAATTAGGATCCTATAAGT
ATGGCA
ACGTTGAATTCTCTCTTTAAGTTAATGC
TAATCTA

Ohr-Comp-R
msaABCR :: Pohr-F
msaABCR :: pohr-R
For MsaB protein expression
UpA

AGATGGATCCTTGAACGCGTCCGAATA
CTTGTAA
TTAATGGTGATGATGGTGATGTAGTTTA
ACAACGTTTGCAGCTTGT
TACATCACCATCATCACCATTAATTCTT
AGATTTGAATCATTGATTTTA
AGATGAATTCGAAGTTATAAAGCGACA
ATCGTTAAGACAACT

UpB
DnC
DnD
a

Restriction sites are underlined, bEMSA; Electrophoretic mobility shift assay;

c

ChIP; Chromatin Immunoprecipitation
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